Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide.

SB

Steven Bartlett

@StevenBartlett · X

Andrew Huberman's trick for falling back asleep at 3am: a pattern of eye movements under closed eyelids that shuts down the proprioceptive circuits in your cerebellum. "It costs nothing and it generally works." @hubermanlab https://t.co/KX7ztJ5iqd https://t.co/6d8TP3s2CM

DS

David Sinclair

@davidasinclair · X

@cremieuxrecueil Are you paid to post this? Read the scientific literature https://t.co/VLGOlmRM1F https://t.co/TGA9i3SqOP

AÇ

Ahmet Çığşar

@ahmetcigsar · X

Aramaya üşenen, aradığını bulamayanalr için şuraya bırakayım. Dil bariyeri varsa Türkçe dublajlı izleyebilirsiniz. https://t.co/up98yPzML2

RM

Roger Seheult, MD

@RogerSeheult · X

@hubermanlab and @StevenBartlett on the Diary of a CEO podcast. A lot of great protocols just dropped 1 million views in 15 hours. ? Right here ? https://t.co/M3Fm4oyNVC

Source: https://t.co/HCO6Ukmoek

J

Juancho

@juanchosaravia · X

@StevenBartlett @hubermanlab it's deep red light, the glenn jeffrey studies he cites used 670nm. you look at it for 1 to 3 min a couple times a week, and only in the first 3 hours after waking. he goes through it here https://t.co/KGboeIiqWW

SB

Steven Bartlett

@StevenBartlett · X

@hubermanlab https://t.co/KX7ztJ5iqd

VS

Vinícius Silva

@viniciusxsilva_ · X

19.10.2026 | 292/365 | Studying & Coding 1. G. Notebook, ChatGPT, Claude, Antigravity + 2. Eng. software, Seg. Info., Dados + 3. A. Karpathy, freeCodeCamp + 4. E. Algoritmos, Software + https://t.co/moYsS5GtRt

L

Liminal ?

@notesinbetween · X

@arcadiv Да, сам диабет тоже повышает риск проблем со зрением. Но здесь речь о конкретном поражении зрительного нерва. Исследование в JAMA Ophthalmology обнаружило связь с приёмом семаглутида, хотя само по себе не доказывало причинность: https://t.co/7ayB5rhVgV. А в 2025 году EMA,

ZS

ZAMFIROIU SPIRIDON

@DONISROI · X

Andrew Huberman: Așa îmi optimizez creierul și corpul, zilnic! https://t.co/OyB73MrGlb via @YouTube

SB

Steven Bartlett

@StevenBartlett · X

@hubermanlab https://t.co/KX7ztJ5iqd

CL

Christine Liljeholm

@ChristineLilje2 · X

Andrew Huberman: The Real Reason You Can't Get Deep Sleep & Wake Up Exha... https://t.co/ldd1cKjc3b via @YouTube

SB

Steven Bartlett

@StevenBartlett · X

Andrew Huberman's trick for falling back asleep at 3am: a pattern of eye movements under closed eyelids that shuts down the proprioceptive circuits in your cerebellum. "It costs nothing and it generally works." @hubermanlab https://t.co/KX7ztJ5iqd https://t.co/6d8TP3s2CM

TP

Tom Poole

@TomPoole007 · X

@spenley https://t.co/gNkHE19LXB Ome more. @hubermanlab and @StevenBartlett Bitesize knowledge share using Ai fkr exec summary and visual. I did buy his book also. https://t.co/FPjjQ7KzK3

غ

غ

@ghmygo · X

اشوف كثير تعليقات عن الكورتيزول وانه كل الناس تشوف ان ارتفاعه مضر ما راح اشرح لكن شوفوا ذي الحلقة وبتغير مفاهيمكم عن الموضوع وبتشرح لكم ليش https://t.co/udqV8eL7h7

ML

Mikyah’al Bar-Yashar’al;Southn Kingdom Native:Lewi

@Soultastique · X

Andrew Huberman: The Real Reason You Can't Get Deep Sleep & Wake Up Exha... https://t.co/fnR1qde0zd via @YouTube

GA

Gulin Aktas

@aktasglin · X

Arkadaşlar Andrew Huberman bir Nerobilim uzmanı onun bu videosunu izlemenizi tavsiye ederim.Çok faydalı tabsiyeleri var yaşam adına. @hubermanlab #AndrewHuberman https://t.co/Ft9pdKXfzY

T超

tarachan＠循環器×麻酔×集中治療×超音波

@yumemiruhit · X

結論：たぶんダウト わかりやすくキャッチーですがたぶん違います。 今回、GLP-1受容体作動薬のトルリシティ（デュラグルチド）や、GIP/GLP1受容体作動薬のマンジャロ・ゼップバウンド（チルゼパチド）にも、非動脈炎性前部虚血性視神経症（NAION）の発症リスクに関する注意が追加されました。 https://t.co/43IXCMc8I6

KB

Kurt Blake

@KurtBlakeMD · X

Two separate ophthalmologic adverse event signals have now emerged in the GLP-1 literature. Earlier this year NEJM reported choroidal lymphoid hyperplasia in two patients after starting dulaglutide. The events resolved when the drug was stopped. Now GLP1 association with

BK

BOBObro kake ??

@BobobroK · X

Andrew Huberman: The Real Reason You Can't Get Deep Sleep & Wake Up Exhausted https://t.co/aUzOHK0uYA

TP

Tom Poole

@TomPoole007 · X

.@hubermanlab @StevenBartlett 1. https://t.co/ZOxBfaH3q3 2. https://t.co/WxIUb84AOd 3. https://t.co/2tLxIg0FE6 Great book. Excellent work! Thankyou. #health #longevity #habits https://t.co/vbZnZD37yu

S

SammyArmstrong

@SammyRArmstrong · X

None of these work alone. In Huberman's words, they're "gears in a larger system". How you slept last night shapes how you feel today, and what you do today shapes tonight's sleep. Pick one and start tomorrow morning. Full conversation: https://t.co/LnPNpOn6Oe

CC

Call Me A, Ph.D., M.Cd., C.F.C., K.F.C.

@notyouradvisor · X

@georgalaxy ini menarik buat pengetahuan. Kalau ternyata cortisol emang harus dipush di pagi dari bangun tidur, biar malem udah sisa2 aja, menjelang malem melatoninnya muncul. https://t.co/EEDRl3Ykxq

H

HoldsUp

@HoldsUpApp · X

Full fact-check: https://t.co/7Un86EO9MI

F

Farhod

@abdusa1dov · X

@hubermanlab man rosa hurmat qiladigan professor. #DOAC dagi shu epizodni boshladim) https://t.co/hsqzXgvP2d

MA

Miguel Alvarado

@djmalvarado · X

Full conversation: Andrew Huberman with Steven Bartlett on The Diary of a CEO. https://t.co/V2F7zVzKrv

WI

Winston Zin | CEO @ Impakt

@winstonzin · X

Link to the full episode: https://t.co/sMPUKYGVEL

JO

Joshe Ordonez

@JosheOrdonez · X

here is the full episode https://t.co/Me7sMF3Dz1

JO

Joshe Ordonez

@JosheOrdonez · X

here is the full episode https://t.co/6XdTsnP5SB

EM

Eirene.mar

@looneytunes03 · X

https://t.co/UDZJF4LysC

M

MakBPO

@makbpo · X

How much of your performance at work actually comes down to biology?? To get an answer, we'd recommend this conversation between @StevenBartlett and Stanford neuroscientist @hubermanlab on @thediaryoface ? https://t.co/11nfxTEkYN Happy Friday!

DF

Donna Fegan

@donna_fega57867 · X

Wow - this information is like a bible for living well ? https://t.co/gIquFQFXae

F

FerendlieFire

@ferendlie · X

Worth it https://t.co/sDREO7IenZ

JB

Jerome Brown

@JeromeB16426984 · X

Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of ... https://t.co/pv3CCEzD5C via @YouTube

L

Laura

@LauraAmer47 · X

Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of ... https://t.co/7ugoFzuti9 via @YouTube TWO…of my favorite people!!!!

雨M

雨月/Ugetsu m(__)m改名しました

@pipipi02728450 · X

毎日実践！ヒューバーマン博士の脳と体「最適化」ルーティン https://t.co/V8GIxRG7of @YouTubeより 体の機能を保ち、あるいは改善するために。

JC

Jimmy C

@JConstantinides · X

@Sassafrass_84 You do! Try some techniques of the best! https://t.co/qi4LgjfECZ

JC

Jimmy C

@JConstantinides · X

I can't wait to get my copy of Protocols and see @hubermanlab at Radio City! But this was a great appetizer! Watch! https://t.co/Ub14qDW6da

P

Peptriva

@Peptriva · X

Sources, so you can check us: Sinclair on JRE #2537, Aug 7 2026. The vision section starts at 54:40. Huberman on The Diary Of A CEO, Sep 3 2026. His answer starts at 1:10:20. https://t.co/wRulEv3XE4 Rizzo et al, JAMA Ophthalmology, July 3 2024: https://t.co/uAohJMejwl EMA https://t.co/I2iBA0L85G

?

&

@HatimNizam · X

When the ? meets the ? https://t.co/uBHSDNo6Mg via @YouTube

T

TheInternetHadSoMuchPotentialForGood

@asleepv_v · X

@zeta_globin Huberman says meditators can shave an hour off their sleep if they meditate 20 min a day. Science behind it here. https://t.co/fohV1vO5ql

X

xiaoyaozi

@XiaohuaY45395 · X

https://t.co/oZz9v3ET3g 人体使用手册 完整版

AF

Adrian Franc

@SandHchoices · X

Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of Them Daily ... #HealthyLiving #NatureVibes https://t.co/aJw98y6Rjg via @YouTube

R

Rocky

@rsvp89 · X

Cortisol levels affect a lot. #exercise #health https://t.co/Q3X4GHGNmC

CL

Cự Lê

@lecuvan98 · X

Andrew Huberman: Thói Quen Đỉnh Cao Giúp Não & Cơ Thể Mạnh Khỏe Mỗi Ngày! https://t.co/7DzNF2xTvO via @YouTube

W

whitecloud

@mywaytheway · X

Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of ... https://t.co/sYJ6NxRMzl via @YouTube

C

Camus

@newstart_2024 · X

Credit: @hubermanlab on @StevenBartlett's Diary Of A CEO. Full episode: https://t.co/h1Osco9uce

GC

Gunes dogar, gercek elbet cikar.

@baharyakinda · X

Andrew Huberman: Beyin ve Bedeninizi Yücelten Günlük Rutinim! https://t.co/r0qGmpePZi @YouTube aracılığıyla

J

jim

@jimsbr · X

Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of ... https://t.co/EGPdWsuNSN via @YouTube

PI

Padha Likha Insaan

@Padhalikhainsan · X

one of the best podcast right now on internet. https://t.co/VXUFti2IkB

BV

BARAD VICTORINE

@Baradbak · X

Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of ... https://t.co/iSKw4vqXpe via @YouTube

R

Rockport

@RockportAI · X

Watch the full episode with Andrew Huberman on Diary of a CEO: https://t.co/62BNoT2VvB

M

Max

@maxwnichols · X

Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of ... https://t.co/5ZI8sAnY4A via @YouTube

MA

mike ahuja

@mikeahuja · X

Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of ... https://t.co/tSPFZKKktD via @YouTube

L

leo

@leodavincs3 · X

@marclou Health is truly very important; I recommend this video. https://t.co/2svLFhgHWx

AÇ

Ahmet Çığşar

@ahmetcigsar · X

Aramaya üşenen, aradığını bulamayanalr için şuraya bırakayım. Dil bariyeri varsa Türkçe dublajlı izleyebilirsiniz. https://t.co/up98yPzML2

PS

Pablo Spoliansky

@spoliansky25591 · X

@jeremyausmus @jeremyausmus found this PhD from Stanford breaking down, sleep, stress management and much more! I think you may dig it. https://t.co/RTQoCfnqcF

AM

Andres Melo

@andresmelocou · X

#PaLosCreyentesDeColombia ???? Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of ... https://t.co/0chvme4S2E via @YouTube

I

Isabel

@IsabelcIsabel · X

https://t.co/34ihtX1Lfs

BB

Barbara Bogdanska

@BarbaraGajowa · X

Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of ... https://t.co/CJ5vedVju3 via @YouTube

D如

DJ菅(すが)みんa.k.a.右大臣-如雷????????

@Gods_Angels2027 · X

毎日実践！ヒューバーマン博士の脳と体「最適化」ルーティン https://t.co/tRSou1k7F9

EK

etha khan

@ethakhan · X

Amazing human discussion- starting with Sunlight and nature’s impact on our health- why office light (LED)degrade our Mitochondria and metabolism and sleep! Well done Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of ... https://t.co/XlxnnODpFE

CW

Christiane Wolters

@dokgoth · X

OMG people..take the time.... Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of ... https://t.co/rKFbfAHxvK via @YouTube

C

Camus

@newstart_2024 · X

@hubermanlab with @StevenBartlett on Diary of a CEO. Full episode: https://t.co/zdTVRubpT6

P

Peptriva

@Peptriva · X

Sources: Huberman on The Diary Of A CEO, Sep 3: https://t.co/wRulEv3XE4 Saturday's Case File 001, the Soviet program that produced pinealon and Epitalon: https://t.co/zJgl1dAlPI FILE 001 HOOK ID] Attia v Tatem, the BPC-157 debate scored round by round: https://t.co/2shtB4rjOt

R

roninchriswhite

@roninchriswhite · X

Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of ... https://t.co/KgkGh7RYVO via @YouTube

T

Tim

@v_tim_7 · X

Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of These Every Day! https://t.co/o45QwGQTR9

H

HengShiouSheu

@HengSheu · X

皮質醇、補水與晨間自然光的討論，約從 04:04 開始： https://t.co/7yjbWyZWMu

MH

Miguel Hidalgo

@MiguelH87170890 · X

https://t.co/EsrQIYBaw1

H

HengShiouSheu

@HengSheu · X

實驗來自 Andrew Huberman 這段訪談。我不把影片內容直接當結論，只挑低門檻行動實測： https://t.co/uC22T26LUu

S

Spock

@Spocklogics · X

https://t.co/zoocFSHpvh

H

HoldsUp

@HoldsUpApp · X

@questmoosa What to actually do with this, 8 checked takeaways: https://t.co/WHqFPtOpPR

Ţℵ

??ţ☯?ภҜŕчρţ☯Ҝɨ?ģ​?​​?​​?​​?​​?ℵ​???​​

@KtownKryp0King · X

@jockowillink @Ericthomasbtc @LesBrown77 @davidgoggins @DrAndyGalpin @hubermanlab @YourWorldWithin @iameddiepinero @joerogan @Dorian_Yates @TheBranchWarren @jonschoeff @ThomasDeLauer @slipknot @PierrePoilievre @dsimieritsch @TheNotoriousMMA @ChrisStapleton @grok @suno @andyfrisella @GenFlynn @OfficialJimRohn @davidasinclair @NCIUniversity @danawhite @Camilalluiz @DallasMcCarver Andrew @hubermanlab -My Exact Routine To Optimize Brain & Body, I Do All Of These Every Day! @Diary_Of_A_CEO https://t.co/VaDkF9Sp2W #ExtersPyramid #Cancerprotocol #ufc #Silver #Gold #fitness #gymshark #bodybuilding #tezostuesday #biotech #mindovermatter #BCPOLI #tradewar

BM

Bete Moreira

@Elizabe81327828 · X

https://t.co/K31INKaYEx . UTILIDADE PÚBLICA.

R

rasc

@kozmos_ · X

Andrew Huberman is such a great blessing to humanity. Good stuff. https://t.co/r4qSHjhdji

WK

Wisdom from the Greater Community Way of Knowledge

@FromTheMystery · X

Knowledge for the Pillar of Health. https://t.co/9qGAQqQMgT

RM

Roger Seheult, MD

@RogerSeheult · X

@hubermanlab and @StevenBartlett on the Diary of a CEO podcast. A lot of great protocols just dropped 1 million views in 15 hours. ? Right here ? https://t.co/M3Fm4oyNVC

ぴ

ぴじょ

@cyamny · X

朝 ベッドでストレッチ中に聞く メラトニンをメラトヒトや赤外線をアカガイセンとか話すけど、日本語で聞ける https://t.co/3h2EnfCbnl

H

HoldsUp

@HoldsUpApp · X

@newstart_2024 @hubermanlab @StevenBartlett https://t.co/7Un86ENBXa

RP

Rishi Persad ?

@StewChicken42 · X

@RealDoctorMike ? https://t.co/LqEUDSB03C

PR

Peter Rodriguez

@formulacaptial1 · X

https://t.co/vFyFHUY7PX

C

Camus

@newstart_2024 · X

@hubermanlab on Diary of a CEO with @StevenBartlett Episode: https://t.co/h1Osco9uce

D

DataEatsWorld

@dataeatworld · X

Full fact-check: https://t.co/ZgOLWZ9gi4

JW

Jeremy John Wulff

@WulffWulff21 · X

Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of ... https://t.co/h2Dye6xwxx via @YouTube BOOM!

H

HoldsUp

@HoldsUpApp · X

Full breakdown, all 77 claims: https://t.co/7Un86ENBXa

DF

Dana Fleyser

@DANAFLEYSER2 · X

Andrew Huberman: ¿Por qué no logras un sueño profundo y te levantas exha... https://t.co/uc3C66GcHq vía @YouTube #HABITOSSALUDABLES

浅A

浅田　弘法　Hironori Asada

@dochak · X

アンドリュー・ヒューバーマン直伝！熟睡できず朝から疲労困憊の真実 https://t.co/JhGTS71ghV @YouTubeより

KM

Klavs Meijers

@KlavsMeije87068 · X

https://t.co/afKQ3FMMVs

MH

Miguel Hidalgo

@MiguelH87170890 · X

https://t.co/EsCgrmTkWl

G

Garry

@GarryBower75018 · X

https://t.co/7JIE2KUaT3

PY

Peter NguanFatt Yong

@PeterYongSocial · X

https://t.co/p0i1ZCqtMg

A

ArisFox

@ArisFox · X

Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of ... https://t.co/ly41YhGCID via @YouTube

F

Fatiha

@TOURMISS · X

Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of ... https://t.co/gAFWsSstHg via @YouTube is this real @grok ?

K

katakatakitakita

@inikata2kita2 · X

Berikut adalah referensi publikasi ilmiah dan jurnal resmi yang dapat ditelusuri dan dibaca secara langsung: 1. Jurnal Risiko NAION (Kebutaan Parsial/Permanen Saraf Optik) Judul Penelitian: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed

EA

2024=2023+1 (e/acc)

@commondoubts · X

@kiranshaw Survival analyses showed that the risk of developing blindness was highest during the first 12 months following the initial semaglutide prescription. https://t.co/fwRE1acUbl

AY

Ada YU

@AdaYU007 · X

链接：https://t.co/g4b5uhU5kJ

AY

Ada YU

@AdaYU007 · X

抗衰科学家 David Sinclair 在 Joe Rogan 节目上直接放狠话：现在爆火的减肥药 GLP-1，可能会致瞎！ 大家吓一跳，赶紧去查他提到的研究——确实有一项回顾性匹配队列研究发现，吃 GLP-1 的糖尿病患者，36 个月累计 NAION（眼中风致失明）发生率约 8.9%。 但研究只是关联，并没有证明是药物直接导致。 https://t.co/PfgknBGDhv https://t.co/dlOUZfIeCQ

RA

Ry ⭐ (h/acc)

@ryanstellar · X

@Fing00584827490 @MarioNawfal https://t.co/nZbLz8PZ2K

RA

Ry ⭐ (h/acc)

@ryanstellar · X

@m_goes_distance @davidasinclair I thought is was Hathaway What’s the Rizzo study? https://t.co/nZbLz8PZ2K

DS

David Sinclair

@davidasinclair · X

@NocturnalNelly Thanks for clarifying https://t.co/TGA9i3SqOP https://t.co/VLGOlmRM1F

DS

David Sinclair

@davidasinclair · X

@thinkingwest The science https://t.co/TGA9i3SqOP

DS

David Sinclair

@davidasinclair · X

@VigilantFox Reporting the science https://t.co/VLGOlmRM1F https://t.co/TGA9i3SqOP

DS

David Sinclair

@davidasinclair · X

@KanekoaTheGreat Reporting the science https://t.co/VLGOlmRM1F https://t.co/TGA9i3SqOP

DS

David Sinclair

@davidasinclair · X

@daphnezohar Read the science https://t.co/TGA9i3SqOP https://t.co/VLGOlmRM1F

DS

David Sinclair

@davidasinclair · X

@cremieuxrecueil Are you paid to post this? Read the scientific literature https://t.co/VLGOlmRM1F https://t.co/TGA9i3SqOP

H

Himura ?

@aceddeca1 · X

@Hurleygirl111 @KanekoaTheGreat https://t.co/SdIGVH2g3J https://t.co/G78IGpBhPF Use https://t.co/Caohgq1Y75 to do your own research deep dive and it questions and look at the suggested search queries. Nice is all statements or assertions have to have an associated reference which you can then check into

RA

Ry ⭐ (h/acc)

@ryanstellar · X

@daphnezohar 5/100,000 to 10/100,000 https://t.co/nZbLz8PZ2K

G

Grok

@grok · X

@west_west89 @VigilantFox @joerogan @davidasinclair The study Sinclair referenced is by Hathaway, Rizzo et al. in JAMA Ophthalmology (July 2024): https://t.co/SNL8q1nHAg Semaglutide linked to higher NAION risk (HR 4.28 in T2D patients; 7.64 in overweight/obese). Observational only; absolute risk low. The 68.6x NAION / 8x

G

Grok

@grok · X

@degenmitch @MarioNawfal Official FDA prescribing information for Ozempic (revised 2026) is the primary source. It states Ozempic is not recommended in patients with severe gastroparesis, lists severe GI reactions (including postmarketing ileus/obstruction), acute pancreatitis, and acute kidney injury

L

LiveUthing

@LiveUthing · X

@bryan_johnson @maxhodak_ I mean what could possibly go wrong? https://t.co/W4ED87Vj7P

CJ

cyril jose

@drcyriljosen · X

@Nithin0dha NAION or vision loss is now being studied in USA...Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide Jimena Tatiana Hathaway, MD, MPH1,2,3; Madhura P. Shah, BS2,3; David B. Hathaway, MD4 et al...kindly read

SF

Sergio Ferrero

@calotonterias · X

Fuente: https://t.co/r5ii63A9Dh

MC

Mehmethan Celik

@RaqueNNNN · X

@Hushholder @has_elazigli @siyahsancakx https://t.co/POzpeYXLI8

MC

Mehmethan Celik

@RaqueNNNN · X

@Hushholder @has_elazigli @siyahsancakx Kaynak: JAMA Ophthalmology (Temmuz 2024) Makale: "Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide" (Harvard Mass Eye and Ear araştırması, Semaglutide/Ozempic kullananlarda kalıcı görme kaybı/NAION riski)

MH

Murray Horn

@spiderbunny7 · X

@newstart_2024 @DrSuneelDhand Risk of going blind. Go speak to your local ophthalmologist. https://t.co/N0DTVoUEs7

MJ

Mike Johansen

@mikejohansenmd.medsky.social · Bluesky

Literature not super high quality; tirzepatide risk < semaglutide risk. jamanetwork.com/journals/jam...

J

Julio

@JulioFdez79 · X

Algunas fuentes: https://t.co/Tck9HYCdc9 https://t.co/kM3T5DZO1X https://t.co/JZ4oY6t6OH https://t.co/5NnnqjWIUT

D

Deb

@BingoBruno102 · X

https://t.co/ohaWvhWeUf

EH

Emily Heydon

@emilyheydon.bsky.social · Bluesky

anyway I found this study in which 5.5 percent of people who took the drug for weight loss purposes went blind in one eye, so there’s that jamanetwork.com/journals/jam...

AC

Aeryn Christie

@chaoskirin.art · Bluesky

I think we'd need more study to find if this number holds under scrutiny. Even for people who look at this medicine unfavorably, you should want accurate numbers, and this doesn't feel accurate. Source: jamanetwork.com/journals/jam...

M

Marcelo ???

@369marcelo · X

@hpassosneto "Canetinhas" Veja só que absurdo! quantos estão se injetando sem saber destes riscos e como algo assim é liberado ao grande público, não apenas ao paciente com risco/benefício favorável? Qual % das vendas para r/b favoráveis: 1% 5% 10%? CADÊ OS RCT's?!? https://t.co/sQ8jAGV9bN

RH

Rafal Halik

@rafalhalik.bsky.social · Bluesky

Nieprawda.Sa badania obserwacyjne rowniez z cukrzykami i niecukrzykami i wlasnie w tym jest sęk.To, ze stosujesz ten lek nie mowi, ze znasz cale spektrum terapeutycznego tego leku. Problemem jest NAION a on nie jest tylko cukrzycozalezny.Tu publikacja z JAMA jamanetwork.com/journals/jam...

M

Marcelo ???

@369marcelo · X

Cadê as hienas perseguidoras da Dra Tatiana Sampaio, (com sua fascinante, segura e promissora molécula) que NÃO COBRARAM mais segurança destas outras moléculas via 3 ou 4 db RCT's? e que NADA FALAM sobre a aprovação relâmpago das canetinhas ?? Canalhas! https://t.co/Gc1ERDsmrM

SH

Scott C. Howard

@schowardjd · X

A 50/50 split on the poll. Answer: B) Irreversible Non-arteritic ischemic optic neuropathy (NAION) associated with semaglutide results in permanent vision loss. NAION causes acute ischemic injury to the optic nerve, and visual deficits are typically non-reversible, even after

SH

Scott C. Howard

@schowardjd · X

References: 1. Grauslund J, Taha AA, Molander LD, et al. Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes. Int J Retina Vitreous 2024; 10:97. 2. Hathaway JT, Shah MP,

G

Grok

@grok · X

@Sona_unplugged Yes, there are studies on semaglutide and nonarteritic anterior ischemic optic neuropathy (NAION). A 2025 multi-database study (PMC11843465) including oral semaglutide found a modest increased risk (HR 1.3-2.3 vs. comparators). A 2024 JAMA study

C

ChevalGal

@cheval_gal · X

@DowdEdward Or lose your sight https://t.co/7ytARsIJGj

JM

Jeffrey Dach MD

@jeffreydachmd · X

@RealAlexJones When lawyers get involved: This means a bad drug with problems popping up! https://t.co/5RxWRqgSQE ?????? ???? ????-???????? ????? ??????? ??? ???-? ???????? ????????...??????? ???????... Ozempic lawsuits

?

???? ????? ??

@spinesurgeon · X

@senthazalravi Wrong Approach Boss Please read https://t.co/hmjYkG9VqR

FD

Fradi Frad Dreizehn

@frad_fradi · X

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophthalmology | JAMA Network https://t.co/YjAkybvY4f

C

Carl

@StoicConsultant · X

@IPostAndGhost What's more expensive? Being fat or being blind? Once again, I'm nervous about the consequences of the second & third order. https://t.co/pCFW1we5ye

T

TheoRettich

@TheoRettich · X

@figurative1yLit @SamanthaJBryan1 @TheLaurenChen It is. And the condition is irreversible. Robby Williams not only is losing eye sight because of the injections but also developed scurvy, a condition we thought would be long gone. https://t.co/m8fUxbCWsB

JM

Janet Chiang, MD

@JanetMD87 · X

RT @EricTopol: First report of an association of a GLP-1 drug (semaglutide) and risk of NAION, a form of optic neuropathy (2nd most common…

TN

typename_nish

@typename_nish · X

@prabhavkashyapg @ku1deep This is the alternative with serious side effects for what could be achieved by cultivating self discipline https://t.co/iKCZJNMLFB

SB

Scott Braddock

@PAnotalostcause · X

@NathalieAgape @ImBreckWorsham https://t.co/7Xb4AnUgJZ

TL

The LFB

@The_LFB · X

@MdBreathe They are linked to neuropathy: https://t.co/45tqee1r7t

TL

The LFB

@The_LFB · X

@MAHA_Action I guess you want more Americans to go blind. https://t.co/45tqee1r7t

FD

Fradi Frad Dreizehn

@frad_fradi · X

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophthalmology | JAMA Network https://t.co/YjAkybvY4f

AH

Air Hoodlum

@PerfectlyWeird · X

@FridoKala Already being looked at over semaglutide weight loss drugs, more studies are needed before declaring it down to the drug itself, but it's a potential issue https://t.co/Sdge1EHwmX

RT @ehlJAMA: DO GLP-1 Agonists Really Cause Eye Disease There has been a huge amount of press about a report showing an association betwee…

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy with Semaglutide; Diabetic Retinopathy; cumulative incidence of NAION for semaglutide & non–GLP-1 RA cohorts over 36mth was 8.9% and 1.8%.⬆️risk of NAION receiving semaglutide ([HR], 4.28; P < .001). https://t.co/I29btRKcou

RT @JAMAOphth:

RT @JAMAOphth:

RT @JAMAOphth:

RT @JAMAOphth:

RT @JAMAOphth:

RT @JAMAOphth:

RT @JAMAOphth:

RT @JAMAOphth:

RT @JAMAOphth:

https://t.co/NG9Ra15VqU

LN

Longtail News

@longtail-news.bsky.social · Bluesky

Feed: "MashupMD" By: Mashup MD on Monday, August 25, 2025

RT @JAMAOphth: Most viewed this week from @JAMAophth: #Semaglutide, taken for diabetes or obesity, was associated with non-arteritic anter…

Most viewed this week from @JAMAophth: #Semaglutide, taken for diabetes or obesity, was associated with non-arteritic anterior ischemic optic neuropathy (NAION). https://t.co/5yUPUoCobQ https://t.co/IOY8Lm4SxH

RT @JAMAOphth: Most viewed this week from @JAMAophth: #Semaglutide, taken for diabetes or obesity, was associated with non-arteritic anter…

RT @JAMAOphth: Most viewed this week from @JAMAophth: #Semaglutide, taken for diabetes or obesity, was associated with non-arteritic anter…

Most viewed this week from @JAMAophth: #Semaglutide, taken for diabetes or obesity, was associated with non-arteritic anterior ischemic optic neuropathy (NAION). https://t.co/eDKUG1n6Ku https://t.co/7HipGLd2zD

3. Two types of vision indications NAION— maybe real, maybe not, frequency in the 1/10,000 range. https://t.co/KhMFsdLwWC https://t.co/KwpFmy6mD6 https://t.co/KLArnWYG9C

@cabrn22761720 Dureza isso, né? Separei este dois estudos para ele ler

@MinorityFinge @FringedCanuck You are refering to his .. https://t.co/D9Ik8dmPY5 and you don't know what you are talking about.

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/66SA0GMvtp

RT @kym83810679: @drkeithsiau https://t.co/YdoPCi8ar4 https://t.co/FH8iNfzlf7 https://t.co/dPOViAMcsL

@AnitaPadilla32 @DavidWolfe https://t.co/d4bKDNinr6

RT @JAMAOphth: Most viewed this week from @JAMAophth: #Semaglutide, taken for diabetes or obesity, was associated with non-arteritic ante…

RT @kym83810679: @drkeithsiau https://t.co/YdoPCi8ar4 https://t.co/FH8iNfzlf7 https://t.co/dPOViAMcsL

@drkeithsiau https://t.co/YdoPCi8ar4 https://t.co/FH8iNfzlf7 https://t.co/dPOViAMcsL

RT @JAMAOphth: Most viewed this week from @JAMAophth: #Semaglutide, taken for diabetes or obesity, was associated with non-arteritic ante…

Most viewed this week from @JAMAophth: #Semaglutide, taken for diabetes or obesity, was associated with non-arteritic anterior ischemic optic neuropathy (NAION). https://t.co/IGNOcqc8hx https://t.co/p7tJAmQDT5

RT @JAMAOphth: Most viewed this week from @JAMAophth: #Semaglutide, taken for diabetes or obesity, was associated with non-arteritic ante…

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

Most viewed this week from @JAMAophth: #Semaglutide, taken for diabetes or obesity, was associated with non-arteritic anterior ischemic optic neuropathy (NAION). https://t.co/KWoNXEbzO5 https://t.co/g23k6m5rhQ

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

@HughEdw54983916 @grok @wonderful1s @aaronnpearsall https://t.co/FH8iNfzlf7 https://t.co/QEvuLYWa82 https://t.co/dPOViAMcsL

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

BM

Biohack Yourself Magazine

@biohackyourself · X

Can a popular weight‑loss drug raise the risk of sudden vision loss? A Mass Eye and Ear/Harvard study in JAMA Ophthalmology links semaglutide (Ozempic/Wegovy) to higher rates of nonarteritic anterior ischemic optic neuropathy (NAION), a leading cause of abrupt, often permanent https://t.co/Vbf5k87Bgm

https://t.co/VjYkcY4vRz

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

O

omhvdf

@omhvdf · X

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

Looking around for more sources but it sure seems like: 1. This adds 1 per 10k person-years risk of NAION 2. This increases 8.9% (diabetes) risk of NAION (or 7,64% for obesity). Coming from the EU (tighter regs) and US #ozempic https://t.co/EW2UOja6n5 https://t.co/PZI6L1dvR6

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

RT @MdBreathe: Source: https://t.co/HCO6Ukmoek

Source: https://t.co/HCO6Ukmoek

MM

Mary Talley Bowden MD

@MaryBowdenMD · X

Source: https://t.co/HCO6Ukmoek

JM

Jeffrey Dach MD

@jeffreydachmd · X

@aaronnpearsall https://t.co/5RxWRqgSQE ??? ??????? ??????? ???? ?? ????????? ???? ???????????!#??????????? #ozempic #NAION #Wegovy #Mounjaro #GLPReceptorAgonists, #liraglutide See this reference article: Hathaway, Jimena Tatiana, et

Recently, there have been several reports suggesting that the use of once-weekly semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), is associated with an increased risk of NAION. https://t.co/UJx5GTmSmx

Ooooooh boy. https://t.co/ojW14Er52s https://t.co/Mfx6oz72d7

@IronSage_ https://t.co/rGJfq8RY6K

In type 2 #diabetes patients with no prior eye disorders, #semaglutide or #tirzepatide treatment increased the risk of nonarteritic anterior ischemic optic neuropathy and other optic nerve disorders. ja.ma/4llIYJe

Most viewed this week from @JAMAophth: #Semaglutide, taken for diabetes or obesity, was associated with non-arteritic anterior ischemic optic neuropathy (NAION). https://t.co/K4W8gc8skN https://t.co/tWiaMDWrqh

Most viewed this week from @JAMAophth: #Semaglutide, taken for diabetes or obesity, was associated with non-arteritic anterior ischemic optic neuropathy (NAION). https://t.co/dZWOZM3e5m https://t.co/0QhrjzeIGS

@PeterDiamandis No possible benefit is worth the risk of losing sight, however small that risk is. https://t.co/VxAM49llbx

@epochhealth https://t.co/5RxWRqgSQE

@MellyMnemosyne People who take GLP1 inhibitors are risking their health for something that can, in most cases, be achieved by dietary and lifestyle changes. No benefit is worth losing eyesight, no matter how low the risk of that happening is. https://t.co/VxAM49llbx https://t.co/0otXSWcgX5

@eberilka @DahiliyeDoktoru https://t.co/4mOAFCBycF

@eigenrobot https://t.co/VEnp8h90ML

RT @ehlJAMA: DO GLP-1 Agonists Really Cause Eye Disease There has been a huge amount of press about a report showing an association betwee…

@Mulsorc @Dr_Alice_Woods Такому интеллектуалу наверное не трудно будет погуглить, кто и как проводит большинство исследований и на чьи бабки. Но я не отговариваю. Пейте на здоровье свой оземпик. Биг фарма никогда раньше людей не колечила, с чего б ей начинать? https://t.co/ZV3eziWhHL

Ophthopedia Update: Comment on: The Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy: Dear Editor, #Ophthalmology #Ophthotwitter #Scicomm

Ophthopedia Update: Reply to Comment on The Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy: We would like to thank Dr. Hsu, Dr. Lin, and colleagues for their thoughtful commentary on our work evaluating the… #Ophthalmology #Ophthotwitter #Scicomm

眼科領域は引き続き注意深くみてく必要を感じる ほか https://t.co/8SSlx7l0jr https://t.co/4mUJhfZ0P5

Problemas intentinales graves: https://t.co/QC1kS3PU44 Achica el miocardio: https://t.co/o5qYSHQh7V Aumenta el riesgo de neuropatía óptica: https://t.co/MpyZfA8RoE + https://t.co/7lwa4eObe5 Etcetc. Hay mucha propaganda a favor hoy en día, pero banquen unos años.

@jsenior64 @alejoromanmd 1. Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide. Hathaway JT, Shah MP, Hathaway DB, et al. JAMA Ophthalmology. 2024;142(8):732-739. doi:10.1001/jamaophthalmol.2024.2296.

@SergioAmaya88 @alejoromanmd Ahí está en el trino las referencias. Este es una de ellas. https://t.co/5G3O5a8Yf6

JM

Jeffrey Dach MD

@jeffreydachmd · X

@VigilantFox https://t.co/5RxWRqgSQE ??? ??????? ??????? ???? ?? ????????? ???? ???????????! #??????????? #ozempic #NAION #Wegovy #Mounjaro #GLPReceptorAgonists, #liraglutide Hathaway, Jimena Tatiana, et al. "Risk of nonarteritic https://t.co/edtN5B4oqB

確かに多いな＞セマグルチドーNAION https://t.co/aIGIFuTn7Q

@VigilantFox #DoNoHarm https://t.co/Qzrna3xjTh

Prenons garde a ces produits anti-obesité. Des risques accru de perte de la vue (neuropathie optique ischémique antérieure) seraient associés au Sémaglutide. Ces risques sont multipliés par 4 pour les diabétiques et par 7 pour les personnes en surpoids. https://t.co/uK6sPljjNd https://t.co/yWkBCiLL1o

No Thx / American Medical Association Jama Network: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy [Blindness] in Patients Rx'd #Semaglutide. #Wegovy #Ozempic #Zepbound #tirzepatide #glucagonlikepeptide1 #GLP1 #receptor #agonists #Diabetes #WeightLoss #MedSky jamanetwork.com/journals/jam...

Ophthopedia Update: Semaglutide May Increase the Longer-Term Risk of NAION in Patients With Diabetes: A retrospective study reported a slightly greater risk of nonarteritic anterior ischemic optic neuropathy (NAION) in patients with type 2 diabetes who took semaglutide vs… #Ophthalmology #News

Does Ozempic increase the risk of nonarteritic anterior ischemic optic neuropathy (NAION)? A lawsuit recently filed in New Jersey is seeking answers.

@DrPops3 @NateB_Panic https://t.co/LpXbdLI2ve

@cremieuxrecueil For certain auto immune conditions there can be some risks (https://t.co/aNJ7g1vCIA), generally GLP-1 is very safe though

Mإ

Madame Folette ⵉⵎⴰⵏ إيمان

@MadameFolette · X

@tchantchea En effet, c’est uniquement destiné aux diabétiques de type deux pas stabilisé. Une étude américaine révèle aussi que les patients sous semaglutide avaient 4 fois plus de risques de devenir aveugles. https://t.co/S226QqCNPH

LS

lucygoosey70.bsky.social

@lucygoosey70.bsky.social · Bluesky

When you go to the actual study, it says there MAY be an association, but more research is needed to determine causality. Your source conveniently left that part out, though it is made clear in the abstract of the paper. jamanetwork.com/journals/jam...

JM

Jeffrey Dach MD

@jeffreydachmd · X

@DrAseemMalhotra https://t.co/5RxWRqgSQE ??? ??????? ??????? ???? ?? ????????? ???? ???????????! #??????????? #ozempic #NAION #Wegovy #Mounjaro #GLPReceptorAgonists, #liraglutide Hathaway, Jimena Tatiana, et al. "Risk of nonarteritic https://t.co/MFjSWGAeuv

Here’s the original single-center study on the topic suggesting risk (@DavidHathawayMD @zekavatm @HMSEye @MassEyeAndEar @HarvardChanSPH): @JAMAOphth paper: https://t.co/YHrIkCBYdJ 2/5

More real world cohort data from TriNetX assessing whether and at what time points semaglutide use in people with #T2D is associated with an increased risk of nonarteritic anterior ischemic optic neuropathy (NAION) jamanetwork.com/journals/jam...

Study of 3 million patients with diabetes found that use of semaglutide (Ozempic) is linked with a 4X greater risk of nonarteritic anterior ischemic optic neuropathy (NAION) compared with non-GLP-1RAs (empagliflozin, sitagliptin, and glipizide). www.ophthalmologyadvisor.com/news/semaglu...

BS

BadCompany @badcompany.bsky.social

@Badioff · X

RT @Elitiker: Am Ende ist man schlank, aber leider blind? Semaglutid steht im Verdacht, das Risiko für die nicht arteriitische anteriore is…

M

M

@MaMt2023 · X

RT @Elitiker: Am Ende ist man schlank, aber leider blind? Semaglutid steht im Verdacht, das Risiko für die nicht arteriitische anteriore is…

G

Gegengift2017

@Gegengift2017 · X

RT @Elitiker: Am Ende ist man schlank, aber leider blind? Semaglutid steht im Verdacht, das Risiko für die nicht arteriitische anteriore is…

GJ

Georg Jonas

@Jonas1955 · X

RT @Elitiker: Am Ende ist man schlank, aber leider blind? Semaglutid steht im Verdacht, das Risiko für die nicht arteriitische anteriore is…

C

CM

@CMMCMLXXI1 · X

RT @Elitiker: Am Ende ist man schlank, aber leider blind? Semaglutid steht im Verdacht, das Risiko für die nicht arteriitische anteriore is…

E

eli

@Elitiker · X

Am Ende ist man schlank, aber leider blind? Semaglutid steht im Verdacht, das Risiko für die nicht arteriitische anteriore ischämische Optikus-Neuropathie (NAION) zu erhöhen, je nach Studie um das bis 4-fache. https://t.co/7Ykc3fmO5v https://t.co/eaMgUlZ2ky

@chiragbarjatyaa Genuine question, there have been recent reports of vision loss in a% of people who have consumed semaglutide. Is it still safe to consume for obese people. https://t.co/xJig4dnoVC

Ophthopedia Update: This Issue at a Glance: Using data from a deidentified global electronic medical records database, Chou et al (p. 381) retrospectively investigated whether semaglutide increases the risk of nonarteritic anterior ischemic optic neuropathy… #Ophthalmology #ophthotwitter #eyecare

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | JAMA Ophthalmology- $VKTX VK2735 is to $NVO Ozempic & $LLY Zepbound (not Semaglutide but implicated In papillitis & maculopathy) as Revlimid is to Thalidomide. https://t.co/wr6nBfjX3r

Bا

BASEM BAHRANI باسم البحراني

@basemstat · X

@SaudiNews50 ?الدراسة المشار لها تم نشرها في مجلة JAMA Opthalmology استخدمت بيانات 16,827 مريض تم تقييمهم بين ديسمبر 2017 ونوفمبر 2023 تم نشر الدراسة في شهر يوليو ٢٠٢٤ هذه الدراسة أجراها باحثون من Mass Eye and Ear و جامعة هارڤارد ?عنوان الدراسة هو Risk of Nonarteritic Anterior Ischemic

JM

Jeffrey Dach MD

@jeffreydachmd · X

@MidwesternDoc https://t.co/5RxWRqgSQE ??? ??????? ??????? ???? ?? ????????? ???? ???????????! #??????????? #ozempic #NAION #Wegovy #Mounjaro #GLPReceptorAgonists, #liraglutide Hathaway, Jimena Tatiana, et al. "Risk of nonarteritic https://t.co/smKB553uW3

@leanhealth Can also make you blind. https://t.co/LpXbdLI2ve

RT @Nak_Muay_Thai: I told my friends and family to stay away from this stuff…now people are going blind. Thanks big pharma. https://t.co/oW…

A

Amer

@dwdaai · X

@noir_ism 急性膵炎に加えて非動脈炎性虚血性視神経症」（NAION）による失明リスクについてもまだ決着がついていないので適応外使用は怖くてできません 2024/7後ろ向きコホートではNAION発症リスクと関連あり https://t.co/IwpOpvoM61 2024/11後ろ向きコホートでは関連なし https://t.co/7Uo3ur3Due

@Timcast https://t.co/BleGt4Fu5f

@JulieOnX24 @TheRealKingRosa @Timcast https://t.co/BleGt4Fu5f

@bayeslord https://t.co/NGT1tyBv59 https://t.co/Gu6X8rivs4

Semaglutide Blinds most commonly in the Nondiabetic Cohort- cumulative incidence of NAION of 6.7% (95% CI, 3.6%-9.7%) for the semaglutide cohort vs 0.8% (95% CI, 0%-1.8%) for the nonsemaglutide cohort.” 7x - vs 3x in Diabetic cohort. https://t.co/GsADnRH2J3 $NVO

I told my friends and family to stay away from this stuff…now people are going blind. Thanks big pharma. https://t.co/oWPrgXn915

https://t.co/bFDdmSvtKW

RT @TonyFauci2: Risk of NAION in Nondiabetic Wegovy patients Highly Significant -semaglutide vs non–GLP-1 RA cohorts over 36 months was 6.7…

Risk of NAION in Nondiabetic Wegovy patients Highly Significant -semaglutide vs non–GLP-1 RA cohorts over 36 months was 6.7% (95% CI, 3.6%-9.7%) and 0.8% (95% - P < .001). Get a safer drug $NVO > $VKTX https://t.co/wr6nBfkuSZ

@jacobjamesrich @drsimonegold https://t.co/aAdsc7mIfA

@TXtoDCtoCA @drsimonegold Did anyone bother reading it? They weren't all diabetic? https://t.co/aAdsc7mIfA

@QuantPsychiatry Maybe not that fast https://t.co/NoEztAcIND

@AlegonPepe @UHN_Plus Acá el estudio completo. No se pueden tomar medidas ni recomendar o dejar de recomendar por 9 pacientes en millones que lo reciben. Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/94FivpNlCd

@UHN_Plus Por si a alguien le interesa envío enlace Saquen sus propias conclusiones https://t.co/1onFZegcEh

RT @TonyFauci2: #JAMA on over 600 cases on NAION in Boston : “Given that semaglutide was first approved to treat T2D but plausible confound…

@Jeroz @makutyre @Simpsons_tweets https://t.co/OngEjoLYY6 However; "future study is required to assess causality." So we're going to have to wait a while I guess.

#JAMA on over 600 cases on NAION in Boston : “Given that semaglutide was first approved to treat T2D but plausible confounding factors were not significant contributors to the risk of NAION” $NVO and now $LLY Rxs implicated - not $VKTX https://t.co/Az3PRUvn08

https://t.co/XTBiu1ybfL

NAION is a rare optic nerve disease that can cause permanent blindness. Once it happens, there’s no reversing it.

En un registro de pacientes con neuropatía isquémica óptica, semaglutide en DM y en obesidad. https://t.co/5G3O5a8Yf6

@HilldurG @ZubyMusic https://t.co/d8hKcTNfuq

@mask_bastard Obviously more to the story, but its the Daily mail. https://t.co/NGf5wVQHJI Also being overweight sucks.

they have known about Ozempic and blindness for some time https://t.co/37v3RNoIuS

they have known about Ozempic and blindness for some time https://t.co/W4ILMOdHTY

AR

Alan Roberts

@TheMFingCOO · X

https://t.co/I72TeESPPy

@Jackie__Knowsss https://t.co/r2Q4mkZcDG Here’s a study, it’s a rare condition but yeah I also would not risk it lol. I also saw mentioned that diabetes medications in general are linked to vision problems so there’s that.

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/GbC0k5Oz6s

@YoloSwagQtPi @tuck54378 @Timcast Yeah, that's exactly how science works. Clown. Here's another study with similar results. https://t.co/rwQsKgwatY

Non vorrei dire, ma la cosa si sa da luglio 2024 quando fu pubblicato uno studio, durato 6 anni e che coinvolgeva 17mila pazienti, su rischio neuropatia ottica ischemica anteriore non arteritica o NAION https://t.co/lLgs7x4DBy https://t.co/tOCItiwkx0

@Timcast https://t.co/LJP7UdS0TF Studies are still being conducted and the risk benefit ratio is being assessed. The risk of NAION is extremely small generally. The risks of Diabetic Retinopathy, which can also cause blindness, in untreated patients is higher.

@BaronBoehm @Timcast It's unknown what the mechanism is but it could well have more to do with the rapid pace of weight loss rather than the drug itself https://t.co/HnmiOvTUDZ

Hツ

Horizon to horizon, nothing but mistakes ¯\_(ツ)_/¯

@pewtergod.bsky.social · Bluesky

Anyone out there taking, or thinking about taking Ozempic? If this study is correct, it might cost you your vision. "The Kaplan-Meier survival analysis at 36 months showed a cumulative incidence of NAION of 6.7% (95% CI, 3.6%-9.7%) for the semaglutide cohort vs 0.8%" jamanetwork.com/journals/jam...

RT @ehlJAMA: DO GLP-1 Agonists Really Cause Eye Disease There has been a huge amount of press about a report showing an association betwee…

RT @ehlJAMA: DO GLP-1 Agonists Really Cause Eye Disease There has been a huge amount of press about a report showing an association betwee…

E

endocrinorosero

@endocrinorosero · X

¿Ozempic y riesgo ocular? ?️⚠️ ¿Sabías que algunos estudios lo relacionan con riesgos en la salud ocular? ? ?Un estudio publicado en JAMA Ophthalmology en 2024 encontró una asociación entre el uso de semaglutida y un mayor riesgo de desarrollo de neuropatía óptica https://t.co/qTPvrllTNB

RT @OleksandrKashu2: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/CZfqKbbHsC

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/CZfqKbbHsC

@_parasocial Yeah, the retina just doesn’t do well with big swings in blood sugar. And clearly the diabetes and obesity are the bigger issues, this is something that ophthalmologists are looking in to. https://t.co/TDHoR4noo7

@SmithJane007 @Juliesnark1731

@BEisenhart Too late https://t.co/38iMZRjA6e https://t.co/B9XH58ZOi9

@Annanor @bryan_johnson https://t.co/wr6nBfkuSZ

RT @JAMAOphth: Most Viewed @JAMAOphth 2024: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide

Most Viewed @JAMAOphth 2024: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide

@mtdzen @JanieChuckles @morri_maurizio @DefiantLs Here is (the first) study examining what had been anecdotal association of semaglutide with NAION. Jump to the “limitations” section to read why further study is necessary. https://t.co/SSti3rAHoF

RT @ShineCo2012: @DefiantLs @im_a_Dan Drugs like Ozempic, Wegovy linked to eye condition causing vision loss: https://t.co/DLt7s6tLAi Inves…

@DefiantLs @im_a_Dan Drugs like Ozempic, Wegovy linked to eye condition causing vision loss: https://t.co/DLt7s6tLAi Investigation: https://t.co/6Ronirqn7S https://t.co/cPPPD0q46Y

@DefiantLs https://t.co/znqWyiwaqm

YG

Yudisthra Ganeshadeva

@yudisthra.bsky.social · Bluesky

Just saw this article NAION incidence increased with Semaglutide use. RR around 4.8 jamanetwork.com/journals/jam...

@Techgnostik @BigImpactHumans @DadRetroGamer There is research going on related to this. Don't just blabber some nonsense about no direct proof. It's within the realm of possibilities. https://t.co/BJfWfQ0ziA

https://t.co/yTtYAKjxBr

@tisfortech @BigImpactHumans https://t.co/SKtbWRpHA5

Here is a link to the study. It’s an observational study of over 16K participants. This should be watched carefully. https://t.co/SKtbWRpHA5 https://t.co/Gk4nD7vGMY

JM

Jeffrey Dach MD

@jeffreydachmd · X

https://t.co/5RxWRqgSQE ??? ??????? ??????? ???? ?? ????????? ???? ???????????! #??????????? #ozempic #NAION #Wegovy #Mounjaro #GLPReceptorAgonists, #liraglutide #obesity #diabetes Hathaway, Jimena Tatiana, et al. "Risk https://t.co/YDxnWoFb47

@TheKrzysztoff @MargBarAmerica Ozempic has been linked to a higher incidence of NAION. Even though its a rare disorder, it has an alarmingly increased incidence Increased risk of cancer is significant in patients with history of medullary thyroid cancer https://t.co/M2mvMGN0Rv https://t.co/WYhkf0AsmD

RT @gri999999: Kind of a bummer if you are taking this. https://t.co/ub6VrGh8HX

Kind of a bummer if you are taking this. https://t.co/ub6VrGh8HX

◎参考3 Jimena Tatiana Hathaway, Madhura P Shah, David B Hathaway, et al. : Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide. JAMA Ophthalmol 142(8) : 732-739, 2024. DOI: 10.1001/jamaophthalmol.2024.2296 https://t.co/5f061PGGAI

OniX OnPoint newsletter: Semaglutide Associated with Increased Risk of Nonarteritic Anterior Ischemic Optic Neuropathy www.linkedin.com/pulse/semagl... via @LinkedIn

RT @benryanwriter: STUDY: Ozempic tied to rare blinding condition Patients prescribed Ozempic or Wegovy for diabetes or weight loss had a h…

DM

Dr. Ilin Gilberto de la Torre M.

@IlindelatorreMD · X

Vínculo de semaglutida con riesgo de pérdida de visión, incluso con pequeñas dosis. Aunque poco frecuente. https://t.co/UHAAb5MPwj

AM

Andrew Fortuna ®NT MSc (mBANT)

@andrewfortunaNT · X

Concerning, 2nd study within months of each other again links Ozempic use to ↑ risk of developing a ‘rare’ eye condition that can lead to blindness. Indiscriminate prescribing of Ozempic is going 2 backfire spectacularly 1 day, uv been warned?? https://t.co/sBxCCNOGfi #Gibraltar

JM

JK MD

@jksequoia · X

@SBakerMD You make my day, if the same method of retrospective research shows that meat induce diabetes, you are upset. But if it shows something with semaglutide, the method is suddenly very good. You are a scientific joke, you are sure you are an MD?https://t.co/P4GyXuIC44 As usually you

WB

Wyatt Burp

@dean_roberti · X

@Wherearewe2024 @JaxenReport https://t.co/DbSCwMcHS7

DS

Dr. med. H. Schiffers, MD, MBA, Lean Sensei

@leanhealth · X

Quelle https://t.co/UKcaSwgFtd Zuvor https://t.co/BqJRBBnLTg

RT @Lily4Lily2: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/6ZyHF5yaU7

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/6ZyHF5yaU7

doi:10.1001/jamaophthalmol.2024.2296

S

StillerNP

@Stillernp · X

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophthalmology | JAMA Network https://t.co/DVapEtHW7i

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophthalmology | JAMA Network https://t.co/DVapEtHW7i

R

RockRat

@RockRat2 · X

@BossTradingGrp Old news from this summer, though. What's your source. Is this being circulated as if it is new in your world? Here's my source, from July: https://t.co/hnGEQhYf9l

R

Rightsofar

@Right_so_far · X

@MdBreathe Looks like it can cause sudden blindness as well! (Optic neuropathy). https://t.co/Rj0ynYqmij Look at Figure 1. Over 10% of people with T2 diabetes taking GLP1 had the condition versus 1-2.5% of those who didn't take it. (% depends on if you include only matched or not)

P

Pedro

@pedro_mmb · X

@TechSalut També multiplica per 7 quedar-se cec de la segona causa més comuna. Elon Musk està promocionant (ha fet un tweet). ☢️ https://t.co/LpXbdLI2ve

Y

yoloswag

@og_yoloswag · X

@squareandplane @bobbyunis @tsarnick @elonmusk The study was a review of patient data from one facility: the Neuro-Ophthalmology Clinic at Massachusetts Eye and Ear. Essentially, they *only* looked at people who showed up with undiagnosed symptoms. And it *did not* establish causality. https://t.co/DR3oJm9SLK

?

???????? ?

@Faceles007 · X

@drchapichapo @realjessknight @Jikkyleaks @Barbie530652452 @kevinnbass Blindness https://t.co/4UT43rd1ca https://t.co/PGDZAGtlAC

?

⚜️????????? ?? ????????????

@Maxwild_hd · X

@FoodProfessor Study links Ozempic to higher risk of eye condition that can cause vision loss https://t.co/30UcQph9DP

@kevinnbass Lookup “semaglutide” and “NAION” (Nonarteritic Anterior Ischemic Optic Neuropathy) and tell me how trustworthy it is… https://t.co/vu8YAsbiSF

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/DqQZnp7v0y

SF

Silicon Valley Fodder

@Playerinthgame · X

@Advo_D @DeanBaker13 Which earlier studies? Here the association is reported this past summer in JAMA. https://t.co/yvWUNK8igV

KE

Ketogenic European

@Ketogenic_EU · X

@LittleBabyBasil @DeepFriedWhey @UncleScottiepoo @SweetG32081658 @thetolerantweft The drug has a higher risk to go blind than other drugs, even for non-diabetics https://t.co/hDndlZ45Ni I'm happy it works but not at the cost of going blind? https://t.co/jntoAmV5mn

HF

Harmless Frog

@FrogHarmless · X

@NiomiJA @newstart_2024 >etc There could be an increased risk of a different kind of eye disease. Hard to evaluate the actual risk, but it's a pretty rare condition. https://t.co/TcTuVcfXjC

P

Pedro

@pedro_mmb · X

@drseanmullen Study from Harvard, not good. https://t.co/LpXbdLI2ve

CP

craftum pascal

@craft_pascal · X

@BeckErin1082 https://t.co/IUjnZqcpAt havard study what if you were the one who went blind! pharmacists make preparations and patients overdose on injections! what are the consequences! the next health disaster in the usa after fentanyl

CP

craftum pascal

@craft_pascal · X

@stephane_picpic @Longevity_Inv GLP1 risk of blindness https://t.co/IUjnZqcpAt

CP

craftum pascal

@craft_pascal · X

RISK OF GLP1 BLINDNESS !stop eating your hamburgers that are killing YOU USA - Ozempic (semaglutide),; Byetta (exenatide),; Trulicity (dulaglutide),; Victoza (liraglutide),; Saxenda (liraglutide,; Xultophy (liraglutide/ ...https://t.co/IUjnZqcpAt

CP

craftum pascal

@craft_pascal · X

糖尿病 / GLP1 による失明のリスクに関する完全な研究 / のマンジャロ/ https://t.co/IUjnZqcpAt

HO

Hugh Osmond

@hughosmond · X

@rcolvile Robert What do you think of this research into reports of blindness and other potential side effects? https://t.co/QrEwtdoX2B

H

HelderbergVillage

@HelderbergVill · X

Ozempic https://t.co/oOIqJu5Tiq

@dr_ukio セマグルチドを処方された患者における非動脈性前虚血性視神経障害のリスク GLP1 糖尿病https://t.co/g5laUdKtqk

New study finds potential link between semaglutide (Ozempic, Wegovy) and increased risk of NAION, especially within the first year of treatment. Important implications for patients with DM and obesity. Read more: https://t.co/umnbtYetrB @JAMAOphth #Ophthalmology

@usmansaeedMD I think ozempic is becoming an outstanding option for diabetic and obese patients. Side effects are part of any drug, I personally found interesting the correlation between ozempic and nonarteritic anterior ischemic optic neuropathy. DOI:10.1001/jamaophthalmol.2024.2296

Journal Club SID Wegovy e Ozempic: Perdere Peso o la Vista? - A cura di Maria Vittoria Cicinelli, Roberto Perilli https://t.co/7uOJM2HmMy

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/ItddZKhOA0

RT @JAMAOphth: Listen to an interview with Joseph F. Rizzo III author of "Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patien…

RT @JAMAOphth: Listen to an interview with Joseph F. Rizzo III author of "Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patien…

Listen to an interview with Joseph F. Rizzo III author of "Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide," and Neil M. Bressler. Find the episode on @AMAEdHub. https://t.co/dRfmZfFKlg

RT @lifebiosciences: #ICYMI, a study published in @JAMAOphth by Dr. Joe Rizzo discusses the potential association between semaglutide and #…

#ICYMI, a study published in @JAMAOphth by Dr. Joe Rizzo discusses the potential association between semaglutide and #NAION. Our #PartialEpigeneticReprogramming platform aims to offer the first potential treatment for this rare eye disease. Read here: https://t.co/LdB49B4xDp. https://t.co/UYo1lXwpJg

SP

Sultan Alotaibi, PhD ??

@S_Alotaibi_PhD · X

@Malmehthel A recent study indicated a potential risk of semaglutide of causing NAION. Assessment of the optic nerve should be conducted among GLP-1 agonist users. https://t.co/QWTllCLsY2

SC

Sergio Calleja

@Montecoya · X

Se demuestra riesgo elevado de neuropatía óptica isquémica anterior no arterítica con el uso de semaglutida Cumulative incidence of NAION for the semaglutide vs non–GLP-1 RA cohorts over 36 months was 6.7% and 0.8%, respectively. https://t.co/h3T3EC4x1h

XM

X.M. Meijome ??♥️

@EnferEvidente · X

O sistema de autorización de medicamentos mostra as súas costuras cando pasan estas cousas "Risco de neuropatía óptica isquémica anterior non arterítica en pacientes con receita de semaglutida" https://t.co/UgVLegPW4J https://t.co/bptVhDeonE

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/TVxnuUb8cY

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/5E8epJskrh

AS

Amelia Cook Diabetes Nurse specialist

@AmeliaCookDSN · X

https://t.co/4XsEniAg61 I'm very concerned about retinal risk with glp1s and mounjaro being the newest one , pre proliferative retinopathy being a no-go for mounjaro! any feedback or thoughts ?

AE

Aquarius-elect ?️

@Aquarius3_0 · X

@kacdnp91 1. When clicking the link - immediate warning: "Link not safe" ? X-citing! 2. A pro-active study/report? "Semaglutide linked to cause of vision loss" (Medscape) - referring to a recent JAMA Ophthalmology study - ofc it's not the ?[https://t.co/bTDN921Vy2 ]

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/3q8gWnv498 via @practiceupdate

DI

Doctor Marquez Internista

@juanjmarquez · X

@DrFisioloco Me disculpas que no se compartir el pdf pero con este enlace puedes ver algo https://t.co/2Lg4jnCa9A

IO

Inna Lazar, OD

@drinnalazar · X

https://t.co/pgPAjiQetK

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/nh6Eg7QBvC

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/UcsJxKvvQZ

Did you know? Ozempic might have a blind spot! Dive into the surprising association between ozempic & NAION at https://t.co/umnbtYdVC3 #ophthalmology #ophthotwitter #ozempic

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/qsMAgW0pjw #glp1 #endocrinology #endotwitter

P

Pedro

@pedro_mmb · X

@roxy_mojo Careful with your eyes. 7X increase in 2nd. most common cause of blindness worldwide ? https://t.co/LpXbdLI2ve

دا

د. عبدالله العنزي

@ph_alanazi · X

https://t.co/kKH0LSrMHk In this study, GLP-1 inhibitor simuglutide associated to higher risk of Nonarteritic Anterior Ischemic Optic Neuropathy

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophthalmology | JAMA Network https://t.co/tBT6nR98uN

RT @NeuroscienceNew: “Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide” by Joseph Rizzo et al. JA…

DO

Distracted Observer

@distractoid · X

New blindness risk revealed with O-O-O-Ozempic. More Big Pharma garbage many will regret taking. https://t.co/aBlLfXEh6d

RT @kksheld: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophth…

BT

Blalock-Taussig

@Sinelnikov3 · X

@Farmaenfurecida ? https://t.co/TNuEQIspyQ).

RT @kksheld: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophth…

RT @kksheld: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophth…

RT @kksheld: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophth…

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophthalmology | JAMA Network https://t.co/0EwzUrWnRe

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophthalmology | JAMA Network https://t.co/NdgUJqs6u7

SP

Sultan Alotaibi, PhD ??

@S_Alotaibi_PhD · X

#diabetes #semaglutide A recent study showed a possible association between semaglutide and the development of NAION. #Optometry https://t.co/QWTllCM0NA

S

Saviglia

@Saviglia · X

https://t.co/5hDHw6S7ZM

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/PK6OrAFmLl

Kº

Kelly Smothers aka Ice Princess³³º¹

@zaptrapped · X

@TeahCartel I think it’s important to read the origination documents on most things these days. https://t.co/PcJYxtspON

RT @shashiiyengar: If you are taking Glp1a for wt loss then be sure you have a good health insurance policy with you. You may need it h/t…

DB

Dr. Divya Bajpai ??

@divyaa24 · X

?NAION (nonarteritic anterior ischemic optic neuropathy) is the second most common form of optic neuropathy and a significant cause of blindness amongst adults? ?Retrospective study associates Semglutide with NAION? https://t.co/Jjc2Oa84zY https://t.co/G4CilL33kW

ГП

Гала Перидоловна ??

@olenbaranasalat · X

@YourStupidPuppy @oldLentach https://t.co/j6VRhJMRYG Лол, нет пруфов.

RT @shashiiyengar: If you are taking Glp1a for wt loss then be sure you have a good health insurance policy with you. You may need it h/t…

RT @shashiiyengar: If you are taking Glp1a for wt loss then be sure you have a good health insurance policy with you. You may need it h/t…

If you are taking Glp1a for wt loss then be sure you have a good health insurance policy with you. You may need it h/t @arunkumar3112 @dlifein @TheIraSahay

M

MKGRN

@MKGRN14 · X

GLP-1 (semaglutide) associated with an increased risk of nonarteritic anterior ischemic optic neuropathy (NAION) in patients with type 2 diabetes and/or patients who are overweight. ? The study suggests association- future study to assess causality. https://t.co/1vCJwfXVOI

EG

EM Drug Info Geek

@DrugInfoGeek · X

Interesting association, Semaglutide and inc risk of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Leave it to ophtho to come up with great acronyms (NAION, aka sodium ion) https://t.co/F48JzilAnA #TwitteRx

SR

SinglemaltScotch (WaterCannon/RubberBullets)

@Singlemalt_18 · X

@AAMortazavi Funny how this got swept under the rug... https://t.co/pCEhnyJFWL

RT @MoHossain: The findings suggest a potential risk of #NAION associated with prescriptions for semaglutide .. Risk of Nonarteritic Ante…

Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide https://t.co/sOlRlh7Fmr

里

里の上

@sato_no_ue · X

オゼンピックやっぱリスクありか NAIONねえ、、、 https://t.co/Sn7EfX6ZLL

Ozempic / Semaglutide increases risk of disease that causes blindness (nonarteritic anterior ischemic optic neuropathy - NAION) https://t.co/atYDWjOOfD Great stuff "Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide" (Hathaway 2024)

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/lChGgSut2e #Diabetes#weightloss#Ozempic#Wegovy#NAION

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/lChGgSut2e

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/FuvTDOzSWF

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/WKRGUNf59D

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/SUFid2hFcG https://t.co/C41PWvL8vx

RT @MoHossain: The findings suggest a potential risk of #NAION associated with prescriptions for semaglutide .. Risk of Nonarteritic Ante…

RT @DrYukselUrun:

Semaglutide could cause severe vision loss: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophthalmology | JAMA Network https://t.co/9n4CVgkHMx

RT @DrYukselUrun:

RT @DrYukselUrun:

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide potential risk of NAION associated with prescriptions for semaglutide, but future study is required to assess causality. https://t.co/lv3V62d4NS

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophthalmology | JAMA Network https://t.co/KcaE136Yxu

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide -reduced blood flow without true inflammation of the blood vessels of the eye https://t.co/cIl3JRMOj1 https://t.co/7UrNL2crkE

RT @JohnNosta: KEY READ!

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophthalmology | JAMA Network https://t.co/HnLMt3z6lv

а вот и первые потенциальные проблемы от Оземпика подъехали: у пациентов с диабетом и ожирением, принимавших семаглутид, нашли повышеный шанс развития ишимической оптической нейропатии исследование наблюдательное, выводов о связи одного со вторым пока нет https://t.co/WkGMMPVLtF

KB

Kevin J. Black

@kjbinstl.bsky.social · Bluesky

Ow. 9% is nontrivial risk. ⚕️"The cumulative incidence of NAION (nonarteritic anterior ischemic optic neuropathy) for the semaglutide and non–GLP-1 RA cohorts over 36 months was 8.9% (95% CI, 4.5%-13.1%) and 1.8% (95% CI, 0%-3.5%), respectively." jamanetwork.com/journals/jam...

RT @JohnNosta: KEY READ!

RT @37phoenix: セマグルチドはGLP-1作動薬以外の糖尿病薬と比較して非動脈炎性前部虚血性視神経症のリスク上昇と関連するかもしれない. JAMA Ophtalmol. PMID: 38958939. https://t.co/x1V5Oi2HP9

セマグルチドはGLP-1作動薬以外の糖尿病薬と比較して非動脈炎性前部虚血性視神経症のリスク上昇と関連するかもしれない. JAMA Ophtalmol. PMID: 38958939. https://t.co/x1V5Oi2HP9

RT @JohnNosta:

RT @JohnNosta: KEY READ!

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/s9OaekydOc

RT @NeuroscienceNew: “Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide” by Joseph Rizzo et al. JA…

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophthalmology | JAMA Network https://t.co/SULADbll6a

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide. https://t.co/JCUdbbiRzu

「減肥神針」恐致失明？注射 Ozempic、Wegovy 可能增加罹患 NAION 風險，諾和諾德嚴正看待研究報告。 #減肥神針 #失明 #副作用 https://t.co/qCtZwXdZq9

Blind or Fat? New Study Reveals Ozempic, Wegovy Linked To 'Potentially Blinding Eye Condition' Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/rc0TFThcux

RT @benryanwriter: STUDY: Ozempic tied to rare blinding condition Patients prescribed Ozempic or Wegovy for diabetes or weight loss had a h…

RT @caminalm: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/Co8lP2qxuK

Riesgo de neuropatía óptica isquémica anterior no arterítica en pacientes a los que se les prescribe semaglutida JAMA Ophthalmol. Publicado en línea el 3 de julio de 2024. doi:10.1001/jamaophthalmol.2024.2296

Patients taking semaglutide (Oxempic/ Wegovy) should be aware of its risks! NAION reported… https://t.co/0CG056Yq1C

RT @Ryu04196650Ryu: GLP-1受容体作動薬Semaglutideと非動脈炎性前部虚血性視神経症NAIONのリスクに関する論文 @JAMAOphth (2024) 因果関係はわかりませんが注視したいですね。 Risk of Nonarteritic Anter…

GLP-1受容体作動薬Semaglutideと非動脈炎性前部虚血性視神経症NAIONのリスクに関する論文 @JAMAOphth (2024) 因果関係はわかりませんが注視したいですね。 Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/uzXEYHr0aG

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/Co8lP2qxuK

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/2l7nSWRNGj

حذاري #أوزيمبك قد يسبب #العمى لدى مرضى #السكر و #السمنة #semaglutide Brand names #Ozempic, #Wegovy, #Rybelsus Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/2l7nSWRNGj

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/ZmFGEAxWv0

MH

Martin Michaelis (he/him)

@martmichaelis.bsky.social · Bluesky

There are no pharmacologically active drugs without side effects. It is always about benefit-risk-ratio. ? #MedSky

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/ovUX3Rxwnf

RT @docwas: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA incide…

RT @docwas: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA incide…

RT @docwas: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA incide…

まーたリリーの株が上がるのか Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/e8qeU3XbxF

RT @NeuroscienceNew: “Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide” by Joseph Rizzo et al. JA…

RT @yianniszacharia: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide @SBakerMD @Mangan150 @ProfT…

【JAMA Ophthalmol.July 3, 2024】 Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/NjkN86hwTm

T

9thGenTN

@9thGenTN · X

Hey @DGlaucomflecken when you get back on this side of the pond will you please weigh in on this? Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/YPHlbFDlRA

Hey @DGlaucomflecken when you get back on this side of the pond will you please weigh in on this? Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/YPHlbFDlRA

RT @benryanwriter: STUDY: Ozempic tied to rare blinding condition Patients prescribed Ozempic or Wegovy for diabetes or weight loss had a h…

RT @benryanwriter: STUDY: Ozempic tied to rare blinding condition Patients prescribed Ozempic or Wegovy for diabetes or weight loss had a h…

RT @docwas: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA incide…

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA incidental observation study or a concern? Will need an RCT ⁦@kamleshkhunti⁩ ⁦@AskDrShashank⁩ ⁦@docanoopmisra⁩ https://t.co/c6rFG4y0e2

RT @benryanwriter: STUDY: Ozempic tied to rare blinding condition Patients prescribed Ozempic or Wegovy for diabetes or weight loss had a h…

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophthalmology | JAMA Network

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide @SBakerMD @Mangan150 @ProfTimNoakes @DrPaulMason @TuckerGoodrich https://t.co/r0HCZA0ZZM

RT @JohnNosta: KEY READ!

RT @MoHossain: The findings suggest a potential risk of #NAION associated with prescriptions for semaglutide .. Risk of Nonarteritic Ante…

RT @JohnNosta:

“Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide” by Joseph Rizzo et al. JAMA Opthalmology https://t.co/MuUSyqlr5g 3/3

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | Diabetic Retinopathy | JAMA Ophthalmology | JAMA Network https://t.co/d08FImgI7Q

BH

Brady Holmer

@Brady_H · X

I'll be curious to hear @hubermanlab thoughts on this one... Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide.https://t.co/hRZAMGiH3s

I'll be curious to hear @hubermanlab thoughts on this one... Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide.https://t.co/hRZAMGiH3s

RT @JohnNosta: KEY READ!

KL

Kendra "Gloom is My Beat" Pierre-Louis

@kendrawrites.com · Bluesky

The study if you're curious and to be clear it does not make a causal link- it's retrospective and there are significant caveats. But it's the kind of study whose conclusions should encourage future studies that are better constructed

RT @JohnNosta: KEY READ!

KEY READ!

RT @benryanwriter: STUDY: Ozempic tied to rare blinding condition Patients prescribed Ozempic or Wegovy for diabetes or weight loss had a h…

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/SCfn13ksRY

The findings suggest a potential risk of #NAION associated with prescriptions for semaglutide .. Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide | @JAMA_current https://t.co/3y9phee1mC #blindness #sugar #glp1 #GLP-1 #diabetes https://t.co/BZk9PSVgB1 https://t.co/pW3zUDwDLb

RT @benryanwriter: STUDY: Ozempic tied to rare blinding condition Patients prescribed Ozempic or Wegovy for diabetes or weight loss had a h…

RT @benryanwriter: STUDY: Ozempic tied to rare blinding condition Patients prescribed Ozempic or Wegovy for diabetes or weight loss had a h…

RT @benryanwriter: STUDY: Ozempic tied to rare blinding condition Patients prescribed Ozempic or Wegovy for diabetes or weight loss had a h…

RT @benryanwriter: STUDY: Ozempic tied to rare blinding condition Patients prescribed Ozempic or Wegovy for diabetes or weight loss had a h…

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide https://t.co/x07irnrUL5

RT @benryanwriter: STUDY: Ozempic tied to rare blinding condition Patients prescribed Ozempic or Wegovy for diabetes or weight loss had a h…

STUDY: Ozempic tied to rare blinding condition Patients prescribed Ozempic or Wegovy for diabetes or weight loss had a higher risk of having a potentially blinding eye condition called NAION than similar patients not on the drugs. https://t.co/PqhNnIOQ2i https://t.co/1GaZAFfIO0 https://t.co/uzTTuQTHMS

F

Dr. Manisha Ghei -Autoimmune MD- Praana Integrative & Functional ...

Facebook

Dr. Manisha Ghei -Autoimmune MD- Praana Integrative & Functional Medicine, Sugar Land. 5519 followers · 43 were here. www.praanaim.com Our goal:...

F

Dra. Carla Ferner - Facebook

Facebook

Dra. Carla Ferner. 151 followers · 4 talking about this. Medicina e saúde Médica Imunologista Nutrologia| ABRAN Medicina Integrativa | Hosp Albert Einstein.

F

Eduardo Ontiveros Martínez (@LaloOntiverosMtz) - Facebook

Facebook

☑️JAMA Ophthalmol. 2024;142(8):732-739. doi: 10.1001/jamaophthalmol.2024.2296 #glp1 #diabetes #reading #obesidad #Sobrepeso #pokeendocrino #Endocrinologia ...

F

Phase Plastic Surgery & Longevity Institute Dr. Richard Baxter

Facebook

JAMA Ophthalmol. 2024;142(8):732–739. doi:10.1001/jamaophthalmol. 2024.2296 https://www.aao.org/education/clinical ...

JAMA Ophthalmol. 2024;142(8):732–9. doi: 10.1001/jamaophthalmol.2024.2296. pmid:38958939. 16. Hsu AY, Kuo H-T, Wang Y-H, Lin C-J, Shao Y-C, Chiang C-C, et al ...

N

Does Saving the Kidneys Mean Risking the Eyes? in - Kidney News

News

JAMA Ophthalmol 2024 ; 142 : 732 – 739 . doi: 10.1001/jamaophthalmol.2024.2296 )| false. Search Google Scholar · Export Citation. 4. Early worsening of diabetic ...

B

Glucagon-like Peptide-1 Receptor Agonists and Risk of Nonarteritic ...

Blogs

JAMA Ophthalmol. 2024;142(8):732-739. doi: 10.1001/jamaophthalmol.2024.2296; Hsu AY, Kuo HT, Wang YH, et al. Semaglutide and nonarteritic anterior ischemic ...

I

Canetas emagrecedoras podem afetar os olhos? Um novo estudo ...

Instagram

JAMA Ophthalmology. Publicado online em 3 jul 2024. doi:10.1001/jamaophthalmol.2024.2296. Fonte da notícia: g1, "Anvisa investiga 13 ...

I

Acordar enxergando menos de um olho, sem dor nenhuma. É assim ...

Instagram

JAMA Ophthalmology. Publicado online em 3 jul 2024. doi:10.1001/jamaophthalmol.2024.2296. Fonte da notícia: g1, "Anvisa investiga 13 ...

F

JAMA Ophthalmology - Facebook

Facebook

JAMA Ophthalmology, 2024, DOI: 10.1001/jamaophthalmol. 2024.2296, https://jamanetwork. com/journals/jamaophthalmology/fullarticle/282025 5 ...

I

Caneta emagrecedora causa perda de visão? Os estudos ainda ...

Instagram

doi:10.1001/jamaophthalmol.2024.2296. Fonte da notícia: g1, "Anvisa investiga 13 notificações de doença que causa perda de visão associada a ...

F

No Podnews, o médico cardiologista Hugo Faria aborda ... - Facebook

Facebook

No Podnews, o médico cardiologista Hugo Faria aborda a investigação da Anvisa sobre 13 casos de doença ocular rara associados ao uso de ...

I

https://youtu.be/jFLaCv8VOY8 ДОКУМЕНТАЛНОТО МИ ФИЛМЧЕ ...

Instagram

https://doi.org/10.1001/jamaophthalmol.2024.2296 https://doi.org/10.1371/journal.pmed.1005064 https://doi.org/10.1056/NEJMoa2307563 https ...

JAMA Ophthalmology, 2024, DOI: 10.1001/jamaophthalmol. 2024.2296, https://jamanetwork. com/journals/jamaophthalmology/fullarticle/282025 5 ...

L

Vivos Therapeutics Achieves FDA 510(k) Clearance for OSA Device

LinkedIn

JAMA Ophthalmol. 2024;142(8):732-739. DOI: 10.1001/jamaophthalmol.2024.2296 https://lnkd.in/gpBC7CWM #Rheumatology #ObesityMedicine #GLP1 ...

L

FDA Clears Boston Scientific's SpaceOAR Flex Hydrogel Spacer

LinkedIn

JAMA Ophthalmol. 2024;142(8):732-739. DOI: 10.1001/jamaophthalmol.2024.2296 https://lnkd.in/gpBC7CWM #Rheumatology #ObesityMedicine #GLP1 ...

L

Vivos Therapeutics Achieves FDA 510(k) Clearance for OSA Therapy

LinkedIn

JAMA Ophthalmol. 2024;142(8):732-739. DOI: 10.1001/jamaophthalmol.2024.2296 https://lnkd.in/gpBC7CWM #Rheumatology #ObesityMedicine #GLP1 ...

I

A popularização de medicamentos como a semaglutida ... - Instagram

Instagram

JAMA Ophthalmol. 2024;142(8):732–739. doi:10.1001/jamaophthalmol.2024.2296 *Ophthalmic Complications Associated With the Antidiabetic Drugs ...

L

AMA Publishes CPT Code for Ocular Cooling 1115T - LinkedIn

LinkedIn

JAMA Ophthalmol. 2024;142(8):732-739. DOI: 10.1001/jamaophthalmol.2024.2296 https://lnkd.in/gpBC7CWM #Rheumatology #ObesityMedicine #GLP1 ...

I

️ Ozempic, GLP-1 y tus ojos: lo que debes saber Los ... - Instagram

Instagram

DOI: 10.1001/jamaophthalmol.2024.2296 · PMID: 38958939. #Ozempic #Semaglutida #SaludVisual #NeuropatiaOptica #Diabetes #Oftalmologia ...

F

Other posts - Facebook

Facebook

JAMA Ophthalmology, 2024, DOI: 10.1001/jamaophthalmol. 2024.2296, https://jamanetwork. com/journals/jamaophthalmology/fullarticle/282025 5 ...

I

October 6 - Instagram

Instagram

DOI: 10.1001/jamaophthalmol.2024.2296 · PMID: 38958939. #Ozempic #Semaglutida #SaludVisual #NeuropatiaOptica #Diabetes #Oftalmologia ...

8 (2024): 732–39. https: //doi.org/10.1001/jamaophthalmol.2024.2296. Medicines and Healthcare products Regulatory Agency. “Semaglutide (Wegovy, ...

N

GLP-1s may be linked to vision loss, but risk 'very, very low' - Healio

News

JAMA Ophthalmol. 2024;doi:10.1001/jamaophthalmol.2024.2296. Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass ...

F

Era só uma reforma… até eu resolver derrubar tudo e começar do ...

Facebook

Era só uma reforma… até eu resolver derrubar tudo e começar do zero. Rita e Priscila encararam esse desafio comigo: transformar um ...

F

Você viu a notícia sobre semaglutida e ficou preocupada com a sua ...

Facebook

O risco é muito raro, mas merece atenção. Como médica, considero essencial acompanhar de perto e avaliar o histórico de cada pessoa, incluindo ...

L

SI-BONE Announces FDA Clearance for iFuse Granite Onyx System

LinkedIn

JAMA Ophthalmol. 2024;142(8):732-739. DOI: 10.1001/jamaophthalmol.2024.2296 https://lnkd.in/gpBC7CWM #Rheumatology #ObesityMedicine #GLP1 ...

I

Caneta emagrecedora pode afetar a visão? A Anvisa está ...

Instagram

... 10.1001/jamaophthalmol.2024.2296 Fonte da notícia: g1, "Anvisa investiga 13 notificações de doença que causa perda de visão associada a ...

F

Should you be concerned about the risk of vision loss from GLP-1 ...

Facebook

JAMA Ophthalmol. 2024;142(8):732–739. doi:10.1001/jamaophthalmol. 2024.2296 https://www.aao.org/education/clinical- statement/glucagon-like ...

F

Anvisa investiga casos de perda de visão ligados a canetas ...

Facebook

A Anvisa está investigando 14 casos de cegueira decorrentes de aplicação de canetas emagrecedoras. A agência ainda não encontrou uma relação ...

I

GLP-1 ilaçlarıyla ilgili son dönemde en çok konuşulan ... - Instagram

Instagram

... 10.1001/jamaophthalmol.2024.2296. Cai CX, Hribar M, Baxter S, et al. JAMA Ophthalmology. 2025;143(4):304–314. doi:10.1001/jamaophthalmol ...

I

Cuando un cambio metabólico también puede cambiar ... - Instagram

Instagram

DOI: 10.1001/jamaophthalmol.2024.2296 · PMID: 38958939. #Ozempic #Semaglutida #SaludVisual #NeuropatiaOptica #Diabetes #Oftalmologia ...

I

Tú dijiste: dama la información de la ozempi que está ... - Instagram

Instagram

DOI: 10.1001/jamaophthalmol.2024.2296 · PMID: 38958939. #Ozempic #Semaglutida #SaludVisual #NeuropatiaOptica #Diabetes #Oftalmologia ...

doi:10.1001/jamaophthalmol.2024.2296 • 1.32x across 37.1M adults: Cai et al 2025, JAMA Ophthalmology. doi:10.1001/jamaophthalmol.2024.6555

JAMA Ophthalmology. 2024;142(8):732–739. doi:10.1001/jamaophthalmol.2024.2296. Cai CX, Hribar M, Baxter S, et al. JAMA Ophthalmology. 2025 ...

L

GLP-1 meds linked to vision loss, NAION risk | Kurt Blake posted on ...

LinkedIn

JAMA Ophthalmol. 2024;142(8):732-739. DOI: 10.1001/jamaophthalmol.2024.2296 https://lnkd.in/gpBC7CWM #Rheumatology #ObesityMedicine #GLP1 ...

I

Más del doble de pacientes con diabetes expuestos a AR GLP-1 ...

Instagram

** 2024;142(8):732-739. doi:10.1001/jamaophthalmol.2024.2296. - Li HY, Chan TK, Shih KC, Cheung BMY, Yiu KH, Tse HF, et al. GLP-1 receptor ...

I

ZAYIFLAMA İĞNESİ KULLANIRKEN ANİ GÖRME KAYBI ... - Instagram

Instagram

Kaynaklar Hathaway JT, Shah MP, Hathaway DB, et al. JAMA Ophthalmology. 2024;142(8):732–739. doi:10.1001/jamaophthalmol.2024.2296. Cai CX, ...

L

Emboline Embolic Protection System Receives FDA 510(k ...

LinkedIn

JAMA Ophthalmol. 2024;142(8):732-739. DOI: 10.1001/jamaophthalmol.2024.2296 https://lnkd.in/gpBC7CWM #Rheumatology #ObesityMedicine #GLP1 ...

F

Notificação Azul B e B2 sem complicações! Descubra como vai ...

Facebook

Descubra como vai funcionar a emissão digital de calmantes, indutores do sono e emagrecedores. A Memed já está com tudo pronto para incluir ...

I

As chamadas canetas emagrecedoras ganharam ... - Instagram

Instagram

JAMA Ophthalmology. Publicado online em 3 jul 2024. doi:10.1001/jamaophthalmol.2024.2296. Fonte da notícia:

F

What are the legal options for a class action lawsuit against dry eye ...

Facebook

I do see significant litigation in the future, I suspect that insurance companies will potentially attempt to recoup the costs of any claims ...

Has anyone considered legal action? I appreciate we may all be offended refunds / a small amount to try as a token from years but we have ...

I

"Zayıflama iğnelerinin nadir göz hastalığına yol açabileceği uyarısı ...

Instagram

Kaynaklar Hathaway JT, Shah MP, Hathaway DB, et al. JAMA Ophthalmology. 2024;142(8):732–739. doi:10.1001/jamaophthalmol.2024.2296. Cai CX, ...

F

Do their associations with nonarteritic anterior ischemic optic ...

Facebook

GLP1 #EyeHealth #DiabetesCare #MedicalResearch|Semaglutide & Tirzepatide and other GLP-1RAs work primarily by making you sick.

... 10.1001/jamaophthalmol.2024.2296 #GLP1 #Semaglutide #Ophthalmology #Pharmacovigilance #MedicalEducation. ... doi:10.1001/jamaophthalmol.2024.2296 ...

L

Antipsychotic Medication Side Effects and Patient Care | Dr. Buchi ...

LinkedIn

JAMA Ophthalmol. 2024;142(8):732–739. doi:10.1001/jamaophthalmol.2024.2296 #GLP1 #Semaglutide #Ophthalmology #Pharmacovigilance # ...

L

FDA Peptide Categories from a Pharmacy Perspective | Henry ...

LinkedIn

JAMA Ophthalmol. 2024;142(8):732–739. doi:10.1001/jamaophthalmol.2024.2296 #GLP1 #Semaglutide #Ophthalmology #Pharmacovigilance # ...

L

Women's Health Research Lacking in Medicine and Pharmacology ...

LinkedIn

JAMA Ophthalmol. 2024;142(8):732–739. doi:10.1001/jamaophthalmol.2024.2296 #GLP1 #Semaglutide #Ophthalmology #Pharmacovigilance # ...

I

¿Los GLP-1 son tan peligrosos como dicen en redes? La realidad ...

Instagram

doi: 10.1001/jamaophthalmol.2024.2296. Este fue el estudio que generó gran parte de la preocupación inicial: encontró una asociación entre ...

JAMA Ophthalmol. 2024;142(8):732–739. doi:10.1001/jamaophthalmol.2024.2296 #GLP1 #Semaglutide #Ophthalmology #Pharmacovigilance # ...

F

A farmacêutica EMS anunciou que a primeira caneta de ... - Facebook

Facebook

A versão brasileira chega ao país com o objetivo de ampliar o acesso, uma vez que o tratamento custa cerca de mil reais. A semaglutida é usada ...

L

#laboratorymedicine #medicallaboratory #qualitymanagement ...

LinkedIn

JAMA Ophthalmol. 2024;142(8):732–739. doi:10.1001/jamaophthalmol.2024.2296 #GLP1 #Semaglutide #Ophthalmology #Pharmacovigilance # ...

I

Cały świat od dawna czekał na „tabletkę na odchudzanie”. Wiele ...

Instagram

doi:10.1001/jamaophthalmol.2024.2296 8. Masson W, Lobo M ... doi:10.1001/jama.2021.322416. 11. Semaglutide. In: Wikipedia. ; 2024 ...

F

Cały świat od dawna czekał na „tabletkę na odchudzanie”. Wiele ...

Facebook

doi: 10.1001/jamaophthalmol.2024.2296 8. Masson W, Lobo M ... doi: 10.1001/jama.2021.322416. 11. Semaglutide. In: Wikipedia. ; 2024 ...

F

#rafakalimann #tempoparaamar #nathan - Facebook

Facebook

https: //doi.org/10.1001/jamaophthalmol.2024.2296. Medicines and Healthcare products Regulatory Agency. “Semaglutide (Wegovy, Ozempic and ...

L

Karan Lal DO,MS FAAD's Post - LinkedIn

LinkedIn

To be on th cover of a magazine- pinch me please! For those that know or don't know I have been Rxing GLPs for the past 3 years!

N

Your Patient Is on a GLP-1: A Dermatologist's Guide to What Comes ...

News

... JAMA Ophthalmol. 2024;142(8):732-739. doi:10.1001/jamaophthalmol.2024.2296. Download RIS. Articles in this issue. Previous slide. Next slide.

I

GLP-1 Agonistleri ve Ruh Sağlığı: Lancet Psychiatry 2026 Verileri ...

Instagram

JAMA Ophthalmology. 2024;142(8):732–739. doi:10.1001/jamaophthalmol.2024.2296. Cai CX, Hribar M, Baxter S, et al. JAMA Ophthalmology. 2025 ...

JAMA Ophthalmology, 2024, DOI: 10.1001/jamaophthalmol. 2024.2296, https://jamanetwork. com/journals/jamaophthalmology/fullarticle/282025 5 ...

F

Risk for a rare, potentially blinding eye condition was low, but it was ...

Facebook

Risk for a rare, potentially blinding eye condition was low, but it was significantly higher in diabetes patients who started semaglutide ...

N

Can Ozempic and Wegovy cause eye blindness? - Drugs.com

News

DOI: https://doi.org/10.1001/jamaophthalmol.2024.2296; Hazanchuk, V., et. al. 2024. Can Ozempic Affect Eye Health? Here's What ...

F

We have entered a new era of obesity medicine. The short-term ...

Facebook

... 10.1001/jamaophthalmol. 2024.2296. 33w · 2 likes. Caroline Hobman. Ahh but keeping them on drugs for the rest of their lives keeps the drug ...

I

La neuropatía óptica es una complicación descrita del uso de ...

Instagram

**JAMA Ophthalmol.** 2024;142(8):732-739. doi:10.1001/jamaophthalmol.2024.2296. - Li HY, Chan TK, Shih KC, Cheung BMY, Yiu KH, Tse HF, et al ...

N

Glucagon-like peptide-1 receptor agonists (dulaglutide, liraglutide ...

News

... in Patients Prescribed Semaglutide. JAMA Ophthalmology 142(8): 732-739. DOI: 10.1001/jamaophthalmol.2024.2296 (accessed 2 December 2025).

I

#glp #glp1sideeffects #glp1 - Instagram

Instagram

JAMA Ophthalmol. 2024;142(8):731–739. doi:10.1001/jamaophthalmol.2024.2296. Grauslund J, et al. Once-weekly semaglutide doubles the five-year ...

I

Medscape | Treatment with a GLP-1 receptor agonist (RA) may offer ...

Instagram

JAMA Ophthalmol. 2024;142(8):731–739. doi:10.1001/jamaophthalmol.2024.2296. Grauslund J, et al. Once-weekly semaglutide doubles the five-year ...

I

Canetas emagrecedoras e saúde ocular: o que você precisa saber ...

Instagram

Ref.: doi:10.1001/jamaophthalmol.2024.2296 #Emagrecimento #Saúde #PerdadePeso #SaúdeOcular #DrRafaelCarvalho · June 26. OCR. GRANDES EFEITOS ...

I

Reel by Eva Sarmiento (@farmaciaevasarmiento) · October 27, 2025

Instagram

doi: 10.1001/jamaophthalmol.2024.2296. Este fue el estudio que generó gran parte de la preocupación inicial: encontró una asociación entre ...

F

Semaglutide, a medication used for diabetes and weight ... - Facebook

Facebook

JAMA Ophthalmology, 2024, DOI: 10.1001/jamaophthalmol. 2024.2296, https://jamanetwork. com/journals/jamaophthalmology/fullarticle/282025 5 ...

I

¿Sabías que un medicamento común para la diabetes podría ...

Instagram

DOI: 10.1001/jamaophthalmol.2024.2296 · PMID: 38958939. #Ozempic #Semaglutida #SaludVisual #NeuropatiaOptica #Diabetes #Oftalmologia ...

JAMA Ophthalmol. 2024;142(8):732-739. doi:10.1001/jamaophthalmol.2024.2296. Note, the above observe a correlation and say that new research ...

doi:10.1001/jamaophthalmol.2024.2296. Cai CX, Hribar M, Baxter S, et al. JAMA Ophthalmology. 2025;143(4):304–314. doi:10.1001/jamaophthalmol ...

I

and serious. She joined MHRA's Andy Morling on @gmb to raise ...

Instagram

doi:10.1001/jamaophthalmol.2024.2296 • 1.32x across 37.1M adults: Cai et al 2025, JAMA Ophthalmology. doi:10.1001/jamaophthalmol.2024.6555

I

GLP-1 agonistleri-3 Kullanımı hızla artan bir glukagon benzeri ...

Instagram

doi:10.1001/jamaophthalmol.2024.2296. Cai CX, Hribar M, Baxter S, et al. JAMA Ophthalmology. 2025;143(4):304–314. doi:10.1001/jamaophthalmol ...

F

Semaglutide does not increase the risk of eye disorders or diabetic ...

Facebook

JAMA Ophthalmology, 2024, DOI: 10.1001/jamaophthalmol. 2024.2296, https://jamanetwork. com/journals/jamaophthalmology/fullarticle/282025 5 ...

F

One study found a modest risk of developing non-arteritic anterior ...

Facebook

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition that can lead to ...

I

SIBO'yu sadece “fazla bakteri var” diye tanımlamak, bağırsak ...

Instagram

doi:10.1001/jamaophthalmol.2024.2296. Cai CX, Hribar M, Baxter S, et al. JAMA Ophthalmology. 2025;143(4):304–314. doi:10.1001/jamaophthalmol ...

F

Disestesia: um novo efeito colateral possível dos agonistas de GLP1 ...

Facebook

Em doses muito altas (3x a aprovada para obesidade), 22% relataram esse sintoma (como uma sensação de incômodo/dor na pele ao contato), em ...

F

Léo, filho de Marília Mendonça e Murilo Huff, faz o monitoramento ...

Facebook

Segundo a assessoria do cantor, o uso do dispositivo foi adotado após recomendação médica. O menino, de 5 anos, foi diagnosticado com diabetes ...

N

GLP-1 RA Weight Loss Drugs May Carry Untold Ocular Burden

News

JAMA Ophthalmol. 2024;142(8):732-739. doi:10.1001/jamaophthalmol.2024.2296; Katz BJ, Lee MS, Lincoff NS, et al. Ophthalmic complications ...

NAION (niedokrwienna neuropatia nerwu wzrokowego) może, ale nie musi prowadzić do utraty wzroku. Wyższe ryzyko tego rzadkiego powikłania ...

F

Semaglutide linked to ophthalmic complications like diabetic ...

Facebook

please who is the current President of ANDO?

N

Semaglutide May Increase Nonarteritic Anterior Ischemic Optic ...

News

... 10.1001/jamaophthalmol.2024.2296. Newsletter. Join thousands of clinicians staying current on new therapies, trial data, and expert insights ...

F

The use of semaglutide in patients with diabetes was associated ...

Facebook

JAMA Ophthalmology, 2024, DOI: 10.1001/jamaophthalmol. 2024.2296, https://jamanetwork. com/journals/jamaophthalmology/fullarticle/282025 5 ...

2024.2296. Hsu AY, et al. JAMA Ophthalmol. 2025;doi:10.1001/jamaophthalmol.2025.0349. Susan P. Mollan, MBChB ...

F

Medicamentos como ozempic e wegovy se tornaram os queridinhos ...

Facebook

... 10.1001/jamaophthalmol.2024.2296 doi:10.1001/jamaophthalmol.2024.6058 #drbarakatsemaglutida #drbarakatozempic #ozempic #wegovy #semaglutida ...

N

Semaglutide may raise risk for form of optic neuropathy in adults ...

News

JAMA Ophthalmol. 2024;doi:10.1001/jamaophthalmol.2024.2296), Grausland (Grausland J, et al. Int J Retina Vitreous. 2024;doi: 10.1186/s40942 ...

F

Doktor - Yeni bir çalışma, popüler zayıflama ilaçlarından Ozempic'in ...

Facebook

JAMA Ophthalmol. 2024;142(8):732. doi:10.1001/jamaophthalmol. 2024.2296. ? · ? · ?. Recent posts. Doktor Diyetisyen Olcay Barış. 5d· ?.

I

Could weight loss medications affect your vision? This ... - Instagram

Instagram

JAMA Ophthalmol. 2024 Aug 1;142(8):732-739. doi: 10.1001/jamaophthalmol.2024.2296. PMID: 38958939; PMCID: PMC11223051. Klonoff DC, Hui G ...

N

Semaglutide Linked to Increased Risk of Rare, Debilitating Eye ...

News

... JAMA Ophthalmol. 2024;142(8):732-739. doi:10.1001/jamaophthalmol.2024.2296; Simonsen E, Lund LC, Ernst MT, et al. Use of semaglutide and risk ...

I

Muito feliz em anunciar para vocês minha mais nova parceria para ...

Instagram

https://doi.org/10.1001/jamaophthalmol.2024.2296. Medicines and Healthcare products Regulatory Agency. “Semaglutide (Wegovy, Ozempic and ...

N

BLOG: What would you risk for a miracle? - Healio

News

JAMA Ophthalmol. 2024;doi:10.1001/jamaophthalmol.2024.2296. For more information: John A. Hovanesian, MD, FACS, an ophthalmologist ...

I

A new study determined that Ozempic and Wegovy can help lower ...

Instagram

doi:10.1001/jamaophthalmol.2024.2296 • 1.32x across 37.1M adults: Cai et al 2025, JAMA Ophthalmology. doi:10.1001/jamaophthalmol.2024.6555

I

Fake Ozempic-labelled pens have been caught being imported into ...

Instagram

doi:10.1001/jamaophthalmol.2024.2296 • 1.32x across 37.1M adults: Cai et al 2025, JAMA Ophthalmology. doi:10.1001/jamaophthalmol.2024.6555

I

A Pennsylvania woman's near-death experience after using weight ...

Instagram

doi:10.1001/jamaophthalmol.2024.2296 • 1.32x across 37.1M adults: Cai et al 2025, JAMA Ophthalmology. doi:10.1001/jamaophthalmol.2024.6555

N

Does Saving the Kidneys Mean Risking the Eyes? in - Kidney News

News

JAMA Ophthalmol 2024; 142:732–739. doi: 10.1001/jamaophthalmol.2024.2296. PubMed. Hathaway JT , Risk of nonarteritic anterior ischemic optic ...

... JAMA Ophthalmol. Published online July 3, 2024. doi:10.1001/jamaophthalmol.2024.2296; #Repost @cnnee Síguenos y potencia tus conocimientos ...

Referências 10.1001/jamaophthalmol.2024.2296 doi.org/10.1016/j.ophtha.2024.10.030 10.1016/j.ophtha.2026.02.013

N

Researchers Identify Potential Link Between Semaglutide and ...

News

... JAMA Ophthalmol. July 3, 2024. doi:10.1001/jamaophthalmol.2024.2296; American academy of ophthalmology and north american neuro-ophthalmology ...

I

El pasado 3 de Julio fue publicado en JAMA Ophthalmology un ...

Instagram

... JAMA Ophthalmol. 2024 Jul 3:e242296. doi: 10.1001/jamaophthalmol.2024.2296. Epub ahead of print. PMID: 38958939; PMCID: PMC11223051 ...

F

有時候藥不是沒副作用而是副作用還沒發現#減肥針竟然可能造成失明 ...

Facebook

有時候藥不是沒副作用而是副作用還沒發現#減肥針竟然可能造成失明刊登在2024年7月《美國醫學會眼科學期刊》（JAMA Ophthalmology）的一篇觀察性研究。

F

Pascotto - Istituto per la Salute degli Occhi - Facebook

Facebook

... 10.1001/jamaophthalmol.2024.2296 #SaluteDegliOcchi #CentroOculisticoPascotto #NAION #Semaglutide #Ozempic #Wegovy #Diabete #Obesità ...

N

Semaglutide Linked to Nonarteritic Anterior Ischemic Optic Neuropathy

News

JAMA Ophthalmol. 2024 Jul 3. doi:10.1001/jamaophthalmol.2024.2296. Mollan SP. Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy ...

B

Semaglutide linked to increased risk of severe eye condition NAION ...

Blogs

JAMA Ophthalmology, 2024, DOI: 10.1001/jamaophthalmol.2024.2296, https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2820255.

I

Wegovy), un medicamento para la diabetes tipo 2, y un ... - Instagram

Instagram

JAMA Ophthalmol. Published online July 03, 2024. doi:10.1001/jamaophthalmol.2024.2296. karinagregorym. Y las mandan como si fuesen vitaminas ...

R

מחקר מקשר בין אוזמפיק לסיכון מוגבר למצב עיני שעלול לגרום לאובדן ראייה

Reddit

מחקר מקורי: JAMA Ophthalmol. פורסם אונליין ב-3 ביולי 2024. doi:10.1001/jamaophthalmol.2024.2296 ...

B

Прием препаратов для снижения веса(Ozempic), возможно ...

Blogs

https://doi.org/10.1001/jamaophthalmol.2024.2296 · Добавьте нас в Google. Редакция. Следующая статья Пчелы с высокой точностью обнаруживают ...

F

這幾年大受歡迎的減肥神針：semaglutide，卻被最新醫學研究認為 ...

Facebook

請問一下這個藥是要自費的嗎？？因為我本身 多囊性卵巢外加糖尿病前期還嚴重肥胖，心肺 最近也檢查出來有點問題。想說這個藥是否可 以改變然後協助我減重 ...

F

蔡明劼醫師健康。瘦身added a new photo. - Facebook

Facebook

打瘦瘦針為何會變瘦？三大機轉解析！｜新陳代謝專科蔡明劼 醫師. Garfield Chien and 33 others. 34 reactions · 1 comment · 3 shares.

تحقیق اصلی: JAMA Ophthalmol. منتشر شده آنلاین در ۳ ژوئیه ۲۰۲۴. doi:10.1001/jamaophthalmol.2024.2296 ...

URL: https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2820255 DOI: 10.1001/jamaophthalmol.2024.2296.

Original Research: JAMA Ophthalmol. Publiceret online den 3. juli 2024. doi:10.1001/jamaophthalmol.2024.2296 https://jamanetwork.com ...

Original Research: JAMA Ophthalmol. Published online July 3, 2024. doi:10.1001/jamaophthalmol.2024.2296 https://jamanetwork.com/journals ...

N

Adults prescribed semaglutide may have increased risk for form of ...

News

JAMA Ophthalmol. 2024;doi:10.1001/jamaophthalmol.2024.2296. “The relatively high HRs ... identified by our Cox regression analyses reveal a ...

(doi:10.1001/jamaophthalmol.2024.2296). Editor's Note: Please see the ... 10.1001/jamaophthalmol.2024.2296?guestAccessKey=bb0f187b-7fb2 ...

... 10.1001/jamaophthalmol.2024.2296. ###. About Mass Eye and Ear. Massachusetts Eye and Ear, founded in 1824, is an international center for ...

N

Semaglutide May Be Linked to Condition That Causes Blindness

News

... JAMA Ophthalmol 2024; DOI: 10.1001/jamaophthalmol.2024.2296. Secondary Source. JAMA Ophthalmology. Source Reference: Mollan SP "Semaglutide ...

I

Johann Hari is back on the podcast today and he looks completely ...

Instagram

doi:10.1001/jamaophthalmol.2024.2296 • 1.32x across 37.1M adults: Cai et al 2025, JAMA Ophthalmology. doi:10.1001/jamaophthalmol.2024.6555

F

Glossário de Doenças e Sintomas Einstein - Hospital - Facebook

Facebook

Você sabia que agora pode conferir mais detalhes e informações sobre saúde no Glossário de Doenças e Sintomas disponível em nosso site?

I

"Pharmaceutical company Eli Lilly issued an alert earlier this week ...

Instagram

doi:10.1001/jamaophthalmol.2024.2296 • 1.32x across 37.1M adults: Cai et al 2025, JAMA Ophthalmology. doi:10.1001/jamaophthalmol.2024.6555

I

#ad I am proud to be spreading awareness along with ... - Instagram

Instagram

JAMA Ophthalmol. 2024;142(8):731–739. doi:10.1001/jamaophthalmol.2024.2296. Grauslund J, et al. Once-weekly semaglutide doubles the five-year ...

I

A huge THANK YOU to the PIGA-CDG Brasil Association for raising ...

Instagram

JAMA Ophthalmol. 2024;142(8):731–739. doi:10.1001/jamaophthalmol.2024.2296. Grauslund J, et al. Once-weekly semaglutide doubles the five-year ...

F

“Não é normal as letras se mexerem?” Esta é a pergunta que muitos ...

Facebook

Não é normal as letras se mexerem?” Esta é a pergunta que muitos pacientes fazem após da avaliação do processamento visual, ...

JAMA Ophthalmol. 2024;142(8):732–739. doi:10.1001/jamaophthalmol.2024.2296 https://www.aao.org/education/clinical-statement/glucagon-like ...